N-CSRSfalse0000773757N-1Asemi-annual shareholder report0.0660.0570.0560.0430.0470.9210.0460.1090.2370.1740.1360.1160.0210.0010.0440.4580.1740.153Annualized. 0000773757 2024-05-01 2024-10-31 0000773757 cik0000773757:C000179758Member 2024-05-01 2024-10-31 0000773757 cik0000773757:C000179758Member 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:IndustrialsSectorOneMember 2024-10-31 0000773757 cik0000773757:C000179758Member oef:ConsumerDiscretionarySectorMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:HealthCareSectorOneMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:FinancialsSectorOneMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:OtherSectorMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:LongEquityRiskMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:ShortEquityRiskMember 2024-10-31 0000773757 cik0000773757:C000179758Member us-gaap:CommonStockMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:MoneyMarketFundMember 2024-10-31 0000773757 cik0000773757:C000179758Member oef:CommunicationsSectorMember 2024-10-31 0000773757 cik0000773757:C000179758Member oef:UnclassifiedSectorMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:InformationTechnologySectorOneMember 2024-10-31 0000773757 cik0000773757:C000179758Member oef:IndustrialSectorMember 2024-10-31 0000773757 cik0000773757:C000179758Member us-gaap:FinancialServicesSectorMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:OtherIssueTypeMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:OtherIssueTypeTwoMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:ExchangeTradedEquityFundsMember 2024-10-31 0000773757 cik0000773757:C000179758Member cik0000773757:CommonStocksMember 2024-10-31 0000773757 cik0000773757:C000179758Member oef:InformationTechnologySectorMember 2024-10-31 0000773757 cik0000773757:C000179758Member us-gaap:HealthcareSectorMember 2024-10-31 iso4217:USD xbrli:pure cik0000773757:Holding
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM
N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number
811-04367
Columbia Funds Series Trust I
(Exact name of registrant as specified in charter)

290 Congress Street
Boston, MA 02210
(Address of principal executive offices) (Zip code)

Daniel J. Beckman
c/o Columbia Management Investment Advisers, LLC
290 Congress Street
Boston, MA 02210

Ryan C. Larrenaga, Esq.
c/o Columbia Management Investment Advisers, LLC
290 Congress Street
Boston, MA 02210

(Name and address of agent for service)
Registrant's telephone number, including area code:
(800) 345-6611
Date of fiscal year end:
Last Day of
 
April
Date of reporting period:
October 31, 2024
Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 100
 
F Street, NE, Washington, DC 20549. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
Item 1. Reports to Stockholders
Multi-Manager Directional Alternative Strategies Fund
Institutional Class / CDAZX
FundLogo
Semiannual Shareholder Report | October 31, 2024
This
semiannual shareholder report
contains important information about Multi-Manager Directional Alternative Strategies Fund (the Fund) for the period of May 1, 2024 to October 31, 2024.
You can find additional information about the Fund at
columbiathreadneedleus.com/resources/literature
. You can also request more information by contacting us at
1-800-345-6611.
What were the Fund costs for the reporting period?
(Based on a hypothetical $10,000 investment)
ClassCost of a $10,000 investmentCost paid as a percentage of a $10,000 investment
Institutional Class
$
134
2.53
%
(a)
(a)
Annualized.
Key Fund Statistics
Fund net assets
$
286,272,083
Total number of portfolio holdings810
Portfolio turnover for the reporting period127%
Graphical Representation of Fund
 
Holdings
The tables below show the investment makeup of the Fund represented as a percentage of Fund net assets. Derivatives are excluded from the tables unless otherwise noted. The Fund's portfolio composition is subject to change.
Derivative Exposure
Long
Equity Risk48.1
%
Short
Equity Risk47.8
%
Asset Categories
Graphical Representation - Allocation 1 Chart
Equity Sector Allocation
Graphical Representation - Allocation 2 Chart
Availability of Additional Information
For additional information about the Fund, including its prospectus, financial information, holdings, federal tax information and proxy voting information, visit the Fund’s website included at the beginning of this report or scan the QR code below.
You may obtain the current net asset value (NAV) of Fund shares at no cost by calling 1-800-345-6611 or by sending an e-mail to serviceinquiries@columbiathreadneedle.com.
The Fund is distributed by Columbia Management Investment Distributors, Inc., member FINRA, and managed by Columbia Management Investment Advisers, LLC. Columbia Threadneedle Investments (Columbia Threadneedle) is the global brand name of the Columbia and Threadneedle group of companies. All rights reserved.
© 2024 Columbia Management Investment Advisers, LLC.
Not FDIC or NCUA Insured • No Financial Institution Guarantee • May Lose Value
TSR - QR Code

Item 2. Code of Ethics.

Not applicable.



Item 3. Audit Committee Financial Expert.

Not applicable.



Item 4. Principal Accountant Fees and Services.

Not applicable.



Item 5. Audit Committee of Listed Registrants.

Not applicable.



Item 6. Investments.

(a) The registrant’s “Schedule I – Investments in securities of unaffiliated issuers” (as set forth in 17 CFR 210.12-12) is included in Item 7 of this Form N-CSR.

(b) Not applicable.



Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.



  
Multi-Manager Directional Alternative Strategies Fund
Semiannual Financial Statements and Additional Information
October 31, 2024 (Unaudited)
  
Not FDIC or NCUA Insured
No Financial Institution Guarantee
May Lose Value

Table of Contents
 
3
28
29
30
31
32
44
Multi-Manager Directional Alternative Strategies Fund | 2024

Portfolio of Investments
October 31, 2024 (Unaudited)
(Percentages represent value of investments compared to net assets)
Investments in securities
 
 
Common Stocks 92.1%
Issuer
Shares
Value ($)
Communication Services 10.9%
Diversified Telecommunication Services 1.1%
AT&T, Inc.(a)
23,444
528,428
Deutsche Telekom AG, Registered Shares
13,173
398,266
Telia Co. AB
133,638
388,663
Verizon Communications, Inc.(a)
41,436
1,745,699
Total
3,061,056
Entertainment 2.2%
Live Nation Entertainment, Inc.(a),(b)
4,174
488,942
Spotify Technology SA(a),(b)
13,908
5,355,971
Take-Two Interactive Software, Inc.(b)
3,476
562,139
Total
6,407,052
Interactive Media & Services 6.3%
Alphabet, Inc., Class A(a)
15,087
2,581,536
Alphabet, Inc., Class C(a)
7,952
1,373,231
Cars.com, Inc.(b)
24,599
393,338
Match Group, Inc.(b)
9,286
334,575
Meta Platforms, Inc., Class A(a)
2,729
1,548,926
Reddit, Inc., Class A(a),(b)
92,447
11,028,927
Shutterstock, Inc.(a)
12,001
385,112
Ziff Davis, Inc.(a),(b)
8,220
380,339
Total
18,025,984
Media 1.0%
AMC Networks, Inc., Class A(a),(b)
17,394
140,891
Comcast Corp., Class A(a)
31,644
1,381,894
Informa PLC
59,134
617,765
Omnicom Group, Inc.
4,813
486,113
Vivendi SA
17,802
190,224
Total
2,816,887
Wireless Telecommunication Services 0.3%
T-Mobile US, Inc.(a)
2,900
647,164
Vodafone Group PLC
335,886
312,345
Total
959,509
Total Communication Services
31,270,488
Common Stocks (continued)
Issuer
Shares
Value ($)
Consumer Discretionary 6.7%
Automobile Components 0.6%
Continental AG
766
47,807
Modine Manufacturing Co.(a),(b)
11,116
1,309,131
Sumitomo Electric Industries Ltd.
15,200
233,815
Total
1,590,753
Automobiles 0.1%
Subaru Corp.
13,000
232,170
Broadline Retail 0.4%
Amazon.com, Inc.(a),(b)
2,410
449,224
eBay, Inc.(a)
13,884
798,469
Total
1,247,693
Distributors 0.1%
LKQ Corp.(a)
3,995
146,976
Diversified Consumer Services 0.4%
frontdoor, Inc.(b)
25,638
1,273,952
Hotels, Restaurants & Leisure 1.9%
Booking Holdings, Inc.(a)
318
1,487,047
Boyd Gaming Corp.
8,758
606,842
Churchill Downs, Inc.
4,207
589,401
Domino’s Pizza, Inc.(a)
746
308,643
Flutter Entertainment PLC(b)
3,086
721,915
MGM Resorts International(b)
13,733
506,336
Restaurant Brands International, Inc.
6,456
449,015
Starbucks Corp.
2,083
203,509
Wyndham Hotels & Resorts, Inc.
6,254
552,353
Total
5,425,061
Household Durables 1.5%
Lennar Corp., Class A(a)
4,271
727,351
PulteGroup, Inc.(a)
2,898
375,378
SharkNinja, Inc.(a)
35,305
3,255,474
Total
4,358,203
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
3

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Common Stocks (continued)
Issuer
Shares
Value ($)
Specialty Retail 1.6%
AutoNation, Inc.(b)
1,924
299,124
AutoZone, Inc.(b)
137
412,233
Carvana Co.(b)
12,930
3,197,719
Ross Stores, Inc.
2,124
296,765
TJX Companies, Inc. (The)
4,499
508,522
Total
4,714,363
Textiles, Apparel & Luxury Goods 0.1%
Deckers Outdoor Corp.(a),(b)
600
96,534
Yue Yuen Industrial Holdings Ltd.
42,500
89,340
Total
185,874
Total Consumer Discretionary
19,175,045
Consumer Staples 3.4%
Beverages 0.4%
Constellation Brands, Inc., Class A
1,549
359,895
Molson Coors Beverage Co., Class B(a)
12,354
672,922
Total
1,032,817
Consumer Staples Distribution & Retail 1.1%
BJ’s Wholesale Club Holdings, Inc.(b)
4,271
361,882
Carrefour SA
73,003
1,159,357
J. Sainsbury PLC
40,031
137,818
Target Corp.
3,312
496,932
U.S. Foods Holding Corp.(a),(b)
6,326
389,998
Walmart, Inc.
8,678
711,162
Total
3,257,149
Food Products 1.4%
JM Smucker Co. (The)
3,742
424,754
Kraft Heinz Co. (The)(a)
41,921
1,402,677
Nomad Foods Ltd.
19,335
339,329
Simply Good Foods Co. (The)(b)
10,210
343,669
Tyson Foods, Inc., Class A(a)
8,734
511,725
WH Group Ltd.
1,272,500
990,408
Total
4,012,562
Household Products 0.2%
Central Garden & Pet Co.(a),(b)
6,517
223,533
Essity AB, Class B
10,620
299,825
Total
523,358
Common Stocks (continued)
Issuer
Shares
Value ($)
Tobacco 0.3%
Philip Morris International, Inc.(a)
7,350
975,345
Total Consumer Staples
9,801,231
Energy 2.7%
Energy Equipment & Services 0.4%
Modec, Inc.
8,800
191,614
Schlumberger NV
19,883
796,712
Weatherford International PLC
2,483
196,157
Total
1,184,483
Oil, Gas & Consumable Fuels 2.3%
Canadian Natural Resources Ltd.
14,001
476,314
Cenovus Energy, Inc.
45,621
733,130
Cheniere Energy, Inc.
4,693
898,146
Diamondback Energy, Inc.(a)
5,007
885,087
Dorian LPG Ltd.(a)
4,678
134,960
ENEOS Holdings, Inc.
89,500
451,487
ENI SpA
17,364
264,509
Idemitsu Kosan Co., Ltd.
168,800
1,150,784
Kosmos Energy Ltd.(a),(b)
68,144
256,222
Marathon Petroleum Corp.(a)
3,713
540,130
MEG Energy Corp.
39,251
717,448
Total
6,508,217
Total Energy
7,692,700
Financials 11.6%
Banks 4.5%
AIB Group PLC
41,339
221,620
Bank of America Corp.(a)
26,248
1,097,691
Bankinter SA
19,558
159,562
Barclays Bank PLC
157,066
481,486
BNP Paribas SA
4,238
289,430
BOC Hong Kong Holdings Ltd.
127,500
416,253
Canadian Imperial Bank of Commerce
9,600
600,608
Citigroup, Inc.(a)
17,773
1,140,494
Commerzbank AG
11,339
201,104
East West Bancorp, Inc.(a)
8,176
797,078
Fifth Third Bancorp(a)
9,505
415,179
Hana Financial Group, Inc.
4,692
202,434
Huntington Bancshares, Inc.(a)
54,921
856,218
The accompanying Notes to Financial Statements are an integral part of this statement.
4
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Common Stocks (continued)
Issuer
Shares
Value ($)
ING Groep NV
34,669
588,347
JPMorgan Chase & Co.(a)
8,950
1,986,184
Mitsubishi UFJ Financial Group, Inc.
900
9,486
NatWest Group PLC
77,996
369,565
Nordea Bank Abp
41,675
487,669
Raiffeisen Bank International AG
1,430
25,617
Standard Chartered PLC
35,197
408,158
Sumitomo Mitsui Financial Group, Inc.
6,900
146,380
United Overseas Bank Ltd.
8,100
196,903
Wells Fargo & Co.(a)
27,270
1,770,369
Total
12,867,835
Capital Markets 2.1%
Bank of New York Mellon Corp. (The)(a)
23,606
1,778,948
Blue Owl Capital, Inc.
17,039
380,992
Charles Schwab Corp. (The)
2,324
164,609
Deutsche Bank AG, Registered Shares
72,191
1,226,509
Evercore, Inc., Class A(a)
913
241,187
Goldman Sachs Group, Inc. (The)
541
280,124
LPL Financial Holdings, Inc.
1,840
519,211
Morgan Stanley
4,519
525,334
Northern Trust Corp.(a)
10,478
1,053,249
Total
6,170,163
Consumer Finance 0.6%
American Express Co.
2,281
616,052
Discover Financial Services
4,025
597,431
SLM Corp.(a)
11,312
249,203
Synchrony Financial(a)
2,484
136,968
Total
1,599,654
Financial Services 1.0%
Berkshire Hathaway, Inc., Class B(b)
1,106
498,718
Corebridge Financial, Inc.(a)
41,020
1,303,206
Corpay, Inc.(b)
824
271,689
Fidelity National Information Services, Inc.
3,421
306,966
Fiserv, Inc.(b)
1,196
236,688
Jackson Financial, Inc., Class A(a)
180
17,991
Voya Financial, Inc.
3,408
273,662
Total
2,908,920
Common Stocks (continued)
Issuer
Shares
Value ($)
Insurance 3.4%
Allstate Corp. (The)(a)
8,904
1,660,774
Aon PLC, Class A
2,062
756,486
Arthur J Gallagher & Co.
1,275
358,530
Beazley PLC
40,986
399,542
Chubb Ltd.
1,998
564,315
Everest Group Ltd.
1,615
574,310
First American Financial Corp.
4,557
292,332
Hamilton Insurance Group Ltd., Class B(a),(b)
6,857
119,449
Hyundai Marine & Fire Insurance Co., Ltd.
8,001
175,556
Lancashire Holdings Ltd.
26,074
212,149
Lincoln National Corp.(a)
23,186
805,714
Markel Group, Inc.(b)
293
451,809
MS&AD Insurance Group Holdings, Inc.
50,700
1,121,450
Power Corp. of Canada
25,800
815,498
Progressive Corp. (The)
818
198,635
RenaissanceRe Holdings Ltd.
1,990
522,176
Travelers Companies, Inc. (The)
1,151
283,077
White Mountains Insurance Group Ltd.
162
291,137
WR Berkley Corp.
1,996
114,111
Total
9,717,050
Total Financials
33,263,622
Health Care 15.3%
Biotechnology 2.4%
AbbVie, Inc.(a)
7,108
1,449,108
ADMA Biologics, Inc.(a),(b)
3,292
53,693
Amgen, Inc.(a)
2,626
840,740
Gilead Sciences, Inc.(a)
1,780
158,100
Incyte Corp.(a),(b)
5,687
421,520
Neurocrine Biosciences, Inc.(a),(b)
5,331
641,159
Sarepta Therapeutics, Inc.(a),(b)
25,170
3,171,420
Total
6,735,740
Health Care Equipment & Supplies 6.0%
Abbott Laboratories(a)
5,931
672,397
Boston Scientific Corp.(b)
3,615
303,732
Establishment Labs Holdings, Inc.(a),(b)
39,447
1,699,771
Glaukos Corp.(a),(b)
52,707
6,970,501
Medtronic PLC
7,596
677,943
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
5

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Common Stocks (continued)
Issuer
Shares
Value ($)
PROCEPT BioRobotics Corp.(a),(b)
31,486
2,833,740
RxSight, Inc.(a),(b)
70,561
3,574,620
Stryker Corp.
263
93,702
Zimmer Biomet Holdings, Inc.
2,604
278,420
Total
17,104,826
Health Care Providers & Services 3.6%
AMN Healthcare Services, Inc.(b)
4,123
156,427
Cencora, Inc.(a)
5,851
1,334,496
Centene Corp.(a),(b)
5,767
359,053
Cigna Group (The)(a)
1,892
595,621
CVS Health Corp.(a)
1,100
62,106
DaVita, Inc.(a),(b)
3,875
541,764
Elevance Health, Inc.(a)
1,162
471,493
GeneDx Holdings Corp.(b)
29,331
2,396,049
HCA Healthcare, Inc.
1,267
454,524
Henry Schein, Inc.(b)
1,153
80,975
Humana, Inc.
1,046
269,690
McKesson Corp.
1,194
597,704
Molina Healthcare, Inc.(b)
1,147
368,439
UnitedHealth Group, Inc.
2,708
1,528,666
Universal Health Services, Inc., Class B(a)
4,599
939,622
Total
10,156,629
Life Sciences Tools & Services 0.2%
Avantor, Inc.(a),(b)
8,915
199,429
Fortrea Holdings, Inc.(b)
12,395
208,484
ICON PLC(b)
772
171,469
IQVIA Holdings, Inc.(b)
251
51,661
Thermo Fisher Scientific, Inc.
73
39,881
Total
670,924
Pharmaceuticals 3.1%
AstraZeneca PLC
2,813
400,272
Bristol-Myers Squibb Co.
7,963
444,096
GSK PLC
8,494
153,390
Johnson & Johnson(a)
2,734
437,057
Merck & Co., Inc.(a)
17,805
1,821,808
Novo Nordisk A/S, Class B
899
100,836
Pfizer, Inc.
662
18,735
Roche Holding AG
735
249,799
Common Stocks (continued)
Issuer
Shares
Value ($)
Royalty Pharma PLC, Class A(a)
2,891
78,057
Sandoz Group AG, ADR
11,010
501,927
Sanofi SA
2,204
232,918
SIGA Technologies, Inc.(a)
6,756
48,778
UCB SA
1,447
278,618
Verona Pharma PLC, ADR(b)
79,478
2,696,688
Viatris, Inc.(a)
128,196
1,487,074
Total
8,950,053
Total Health Care
43,618,172
Industrials 13.6%
Aerospace & Defense 1.4%
AAR Corp.(b)
6,910
405,617
Airbus Group SE
2,972
453,353
Curtiss-Wright Corp.
2,193
756,497
Embraer SA, ADR(b)
16,160
541,683
Howmet Aerospace, Inc.(a)
3,300
329,076
Huntington Ingalls Industries, Inc.(a)
2,623
485,150
StandardAero, Inc.(b)
27,750
800,588
Textron, Inc.
4,550
365,911
Total
4,137,875
Air Freight & Logistics 0.4%
CH Robinson Worldwide, Inc.(a)
4,153
427,925
Expeditors International of Washington, Inc.(a)
6,884
819,196
Total
1,247,121
Building Products 2.2%
Advanced Drainage Systems, Inc.
3,636
544,964
Allegion PLC
3,240
452,401
Builders FirstSource, Inc.(b)
4,682
802,495
Carlisle Companies, Inc.(a)
3,591
1,516,228
Masco Corp.(a)
11,614
928,075
MasterBrand, Inc.(b)
13,381
240,323
Owens Corning(a)
3,680
650,587
Resideo Technologies, Inc.(b)
25,977
510,967
Rockwool International A/S, Class B
992
429,288
UFP Industries, Inc.
1,868
228,531
Total
6,303,859
The accompanying Notes to Financial Statements are an integral part of this statement.
6
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Common Stocks (continued)
Issuer
Shares
Value ($)
Commercial Services & Supplies 0.5%
Brink’s Co. (The)
4,888
502,437
Clean Harbors, Inc.(b)
2,265
523,804
Securitas AB
42,654
501,777
Total
1,528,018
Construction & Engineering 1.6%
Eiffage SA
3,435
319,708
EMCOR Group, Inc.(a)
2,777
1,238,736
IES Holdings, Inc.(a),(b)
11,834
2,587,682
Valmont Industries, Inc.
1,241
386,795
Total
4,532,921
Electrical Equipment 0.7%
Acuity Brands, Inc.
2,030
610,401
AMETEK, Inc.
2,109
386,664
Emerson Electric Co.
2,118
229,316
nVent Electric PLC
3,575
266,588
Sensata Technologies Holding
11,152
382,959
Total
1,875,928
Ground Transportation 0.0%
Central Japan Railway Co.
3,200
66,270
Industrial Conglomerates 0.7%
Honeywell International, Inc.
2,995
616,012
Siemens AG, Registered Shares
2,930
570,031
Swire Pacific Ltd., Class A
93,000
778,937
Total
1,964,980
Machinery 2.7%
Allison Transmission Holdings, Inc.
7,851
838,958
Andritz AG
6,283
379,324
Atmus Filtration Technologies, Inc.
6,706
261,132
Dover Corp.
3,535
669,281
Fortive Corp.
3,937
281,220
Miller Industries, Inc.(a)
3,455
226,786
Otis Worldwide Corp.
5,208
511,426
PACCAR, Inc.(a)
16,503
1,720,933
Parker-Hannifin Corp.
512
324,644
Schindler Holding AG
487
141,731
Volvo AB
8,786
230,536
Volvo AB, B Shares
49,986
1,301,977
Common Stocks (continued)
Issuer
Shares
Value ($)
Wartsila OYJ
2,921
55,944
Westinghouse Air Brake Technologies Corp.(a)
3,636
683,495
Total
7,627,387
Marine Transportation 0.2%
AP Moller - Maersk A/S, Class B
283
447,639
Wilh Wilhelmsen ASA
9,317
92,633
Total
540,272
Passenger Airlines 0.0%
Ryanair Holdings PLC, ADR
2,250
99,585
Professional Services 2.0%
Adecco Group AG, Registered Shares
26,062
815,265
Equifax, Inc.
1,446
383,219
Huron Consulting Group, Inc.(b)
4,803
555,851
Jacobs Solutions, Inc.
4,456
626,425
KBR, Inc.
6,302
422,297
Kelly Services, Inc., Class A(a)
7,512
150,165
Leidos Holdings, Inc.(a)
5,136
940,710
Robert Half, Inc.
7,388
503,197
Science Applications International Corp.
2,542
366,785
SS&C Technologies Holdings, Inc.
9,651
674,894
TriNet Group, Inc.
3,732
316,809
Total
5,755,617
Trading Companies & Distributors 0.7%
Beacon Roofing Supply, Inc.(b)
6,934
638,413
Sumitomo Corp.
38,300
807,993
WESCO International, Inc.(a)
2,558
491,059
Total
1,937,465
Transportation Infrastructure 0.5%
Aena SME SA
6,326
1,401,969
Total Industrials
39,019,267
Information Technology 17.4%
Communications Equipment 0.2%
InterDigital, Inc.
3,215
483,665
Electronic Equipment, Instruments & Components 1.6%
Advanced Energy Industries, Inc.
3,682
399,607
Arrow Electronics, Inc.(a),(b)
2,644
313,764
CDW Corp.(a)
1,631
307,003
Celestica, Inc.(b)
700
47,902
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
7

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Common Stocks (continued)
Issuer
Shares
Value ($)
Celestica, Inc.(b)
9,652
660,197
Flex Ltd.(b)
26,623
923,019
Jabil, Inc.(a)
2,360
290,492
Keysight Technologies, Inc.(b)
3,121
465,060
Trimble Navigation Ltd.(b)
6,849
414,365
Zebra Technologies Corp., Class A(b)
1,593
608,478
Total
4,429,887
IT Services 0.4%
Akamai Technologies, Inc.(a),(b)
6,302
637,006
Capgemini SE
2,799
485,573
International Business Machines Corp.(a)
713
147,391
Total
1,269,970
Semiconductors & Semiconductor Equipment 6.9%
Advanced Micro Devices, Inc.(b)
4,109
591,984
Applied Materials, Inc.(a)
6,555
1,190,257
Broadcom, Inc.(a)
4,731
803,182
Cirrus Logic, Inc.(a),(b)
4,443
487,930
KLA Corp.(a)
430
286,479
Lam Research Corp.
7,380
548,703
Microchip Technology, Inc.
5,746
421,584
Micron Technology, Inc.(a)
37,771
3,763,880
MKS Instruments, Inc.(a)
395
39,235
NVIDIA Corp.(a)
35,984
4,777,236
NXP Semiconductors NV(a)
5,897
1,382,846
Photronics, Inc.(a),(b)
15,402
351,166
QUALCOMM, Inc.(a)
6,715
1,093,000
Skyworks Solutions, Inc.(a)
1,553
136,012
Tower Semiconductor Ltd.(a),(b)
89,146
3,740,566
Ultra Clean Holdings, Inc.(a),(b)
3,689
123,397
Total
19,737,457
Software 7.0%
Adeia, Inc.(a)
56,313
699,970
AudioEye, Inc.(b)
60,594
1,290,652
Blend Labs, Inc., Class A(b)
213,744
775,891
Check Point Software Technologies Ltd.(a),(b)
10,460
1,811,777
Datadog, Inc., Class A(a),(b)
16,672
2,091,336
Gen Digital, Inc.(a)
24,834
722,918
Microsoft Corp.(a)
2,922
1,187,355
Common Stocks (continued)
Issuer
Shares
Value ($)
Monday.com Ltd.(a),(b)
20,461
6,012,874
NiCE Ltd., ADR(b)
2,446
424,870
Open Text Corp.
14,300
428,892
Oracle Corp.(a)
3,852
646,520
Pegasystems, Inc.(a)
6,025
478,626
Samsara, Inc., Class A(a),(b)
61,164
2,923,027
Zoom Video Communications, Inc., Class A(a),(b)
7,693
574,975
Total
20,069,683
Technology Hardware, Storage & Peripherals 1.3%
Apple, Inc.(a)
7,207
1,628,133
Dell Technologies, Inc.
4,893
604,922
Hewlett Packard Enterprise Co.
25,790
502,647
NetApp, Inc.
2,710
312,490
Samsung Electronics Co., Ltd.
13,189
560,018
Xerox Holdings Corp.(a)
16,180
132,191
Total
3,740,401
Total Information Technology
49,731,063
Materials 3.7%
Chemicals 1.1%
Celanese Corp., Class A
2,003
252,318
DuPont de Nemours, Inc.(a)
4,834
401,174
Eastman Chemical Co.(a)
4,112
432,130
Evonik Industries AG
21,308
469,611
FMC Corp.
7,410
481,576
Kronos Worldwide, Inc.(a)
13,306
153,551
Methanex Corp.
11,114
435,335
Mosaic Co. (The)
13,972
373,891
Olin Corp.
2,829
116,074
Total
3,115,660
Construction Materials 0.4%
CRH PLC
8,014
764,776
Ferguson Enterprises, Inc.
1,877
369,281
Total
1,134,057
Containers & Packaging 0.1%
Smurfit WestRock PLC
6,045
311,318
The accompanying Notes to Financial Statements are an integral part of this statement.
8
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Common Stocks (continued)
Issuer
Shares
Value ($)
Metals & Mining 2.1%
Barrick Gold Corp.
30,100
581,744
Centerra Gold, Inc.
36,000
254,419
Hudbay Minerals, Inc.
63,246
566,051
Kinross Gold Corp.
80,608
812,528
Kinross Gold Corp.
118,100
1,191,730
Reliance, Inc.
477
136,584
Rio Tinto Ltd.
18,284
1,435,615
Teck Resources Ltd., Class B
15,722
730,916
United States Steel Corp.
7,387
286,985
Total
5,996,572
Total Materials
10,557,607
Real Estate 1.9%
Hotel & Resort REITs 0.0%
Park Hotels & Resorts, Inc.(a)
2,418
33,586
Industrial REITs 0.2%
Americold Realty Trust, Inc.(a)
15,130
388,538
Rexford Industrial Realty, Inc.
5,368
230,234
Total
618,772
Residential REITs 0.1%
Essex Property Trust, Inc.
1,107
314,233
Retail REITs 0.2%
Kimco Realty Corp.
16,212
384,549
Regency Centers Corp.(a)
3,253
232,394
Total
616,943
Specialized REITs 1.4%
American Tower Corp.(a)
7,429
1,586,389
Extra Space Storage, Inc.
1,053
171,955
Lamar Advertising Co., Class A(a)
1,633
215,556
Outfront Media, Inc.(a)
21,183
376,210
SBA Communications Corp.(a)
3,792
870,150
VICI Properties, Inc.
9,848
312,772
Weyerhaeuser Co.
8,868
276,327
Total
3,809,359
Total Real Estate
5,392,893
Common Stocks (continued)
Issuer
Shares
Value ($)
Utilities 4.9%
Electric Utilities 2.4%
American Electric Power Co., Inc.(a)
2,230
220,212
Chubu Electric Power Co., Inc.
8,600
98,858
Enel SpA
96,828
734,351
FirstEnergy Corp.
11,185
467,869
NRG Energy, Inc.(a)
36,055
3,259,372
OGE Energy Corp.
13,577
542,944
PPL Corp.
18,451
600,765
Scottish & Southern Energy PLC
15,076
342,578
Southern Co. (The)
6,214
565,660
Total
6,832,609
Gas Utilities 0.8%
New Jersey Resources Corp.
2,651
121,655
Osaka Gas Co., Ltd.
74,000
1,585,721
Rubis SCA
22,536
552,179
Total
2,259,555
Independent Power and Renewable Electricity Producers 0.6%
Talen Energy Corp.(b)
4,142
751,193
Vistra Corp.
8,317
1,039,293
Total
1,790,486
Multi-Utilities 1.1%
CenterPoint Energy, Inc.
19,361
571,730
Dominion Energy, Inc.(a)
11,185
665,843
Engie SA
73,466
1,231,402
NiSource, Inc.
18,581
653,308
Total
3,122,283
Total Utilities
14,004,933
Total Common Stocks
(Cost $215,843,622)
263,527,021
 
Limited Partnerships 0.3%
 
 
 
Energy 0.3%
Oil, Gas & Consumable Fuels 0.3%
Enterprise Products Partners LP(a)
27,129
777,517
Total Energy
777,517
Total Limited Partnerships
(Cost $793,274)
777,517
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
9

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
 
Preferred Stocks 0.1%
Issuer
 
Shares
Value ($)
Consumer Discretionary 0.0%
Automobiles 0.0%
BMW AG
1,626
119,653
Total Consumer Discretionary
119,653
Consumer Staples 0.1%
Household Products 0.1%
Henkel AG & Co. KGaA
2,462
213,192
Total Consumer Staples
213,192
Total Preferred Stocks
(Cost $338,888)
332,845
 
Warrants —%
Issuer
Shares
Value ($)
Information Technology —%
Software —%
Constellation Software, Inc.(b),(c),(d)
03/31/2040
100
Total Information Technology
Total Warrants
(Cost $—)
 
Call Option Contracts Purchased 0.8%
 
 
 
 
Value ($)
(Cost $2,865,460)
2,365,726
 
Put Option Contracts Purchased 0.9%
 
 
 
 
 
(Cost $3,051,699)
2,620,664
 
Money Market Funds 4.6%
 
Shares
Value ($)
Columbia Short-Term Cash Fund, 5.040%(e),(f)
13,307,533
13,304,871
Total Money Market Funds
(Cost $13,303,742)
13,304,871
Total Investments
(Cost $236,196,685)
282,928,644
 
Investments in Securities Sold Short
 
Common Stocks (45.8)%
Issuer
Shares
Value ($)
Communication Services (1.1)%
Diversified Telecommunication Services (0.6)%
Cellnex Telecom SA
(26,648
)
(978,668
)
Globalstar, Inc.(b)
(115,129
)
(120,886
)
Liberty Global Ltd., Class C(b)
(14,281
)
(294,474
)
Telia Co. AB
(33,784
)
(98,255
)
TELUS Corp.
(13,633
)
(215,508
)
Total
(1,707,791
)
Entertainment (0.1)%
Roblox Corp. Class A(b)
(5,974
)
(308,975
)
Interactive Media & Services (0.1)%
Angi, Inc.(b)
(39,873
)
(94,898
)
Rumble, Inc.(b)
(34,717
)
(202,747
)
Total
(297,645
)
Media (0.3)%
Cable One, Inc.
(554
)
(189,224
)
Clear Channel Outdoor Holdings, Inc.(b)
(128,156
)
(188,389
)
Dentsu, Inc.
(10,300
)
(317,938
)
Fox Corp., Class A
(3,940
)
(165,480
)
Total
(861,031
)
Total Communication Services
(3,175,442
)
Consumer Discretionary (5.6)%
Automobile Components (0.4)%
Luminar Technologies, Inc.(b)
(173,711
)
(134,696
)
Nokian Renkaat OYJ
(65,781
)
(545,972
)
QuantumScape Corp.(b)
(80,354
)
(413,823
)
Total
(1,094,491
)
Automobiles (0.3)%
Lucid Group, Inc.(b)
(15,487
)
(34,226
)
Rivian Automotive, Inc.(b)
(16,090
)
(162,509
)
Tesla, Inc.(b)
(191
)
(47,721
)
Thor Industries, Inc.
(5,557
)
(578,373
)
Total
(822,829
)
Diversified Consumer Services (0.2)%
Mister Car Wash, Inc.(b)
(39,168
)
(294,152
)
Service Corp. International
(4,301
)
(351,176
)
Total
(645,328
)
The accompanying Notes to Financial Statements are an integral part of this statement.
10
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
Hotels, Restaurants & Leisure (3.0)%
Airbnb, Inc., Class A(b)
(29,818
)
(4,019,168
)
Choice Hotels International, Inc.
(3,123
)
(435,690
)
Delivery Hero SE(b)
(9,972
)
(423,333
)
Domino’s Pizza, Inc.
(5,000
)
(2,068,650
)
DraftKings, Inc., Class A(b)
(11,364
)
(401,376
)
InterContinental Hotels Group PLC
(2,461
)
(271,442
)
Krispy Kreme, Inc.
(6,772
)
(76,998
)
Life Time Group Holdings, Inc.(b)
(8,924
)
(198,827
)
Playa Hotels & Resorts NV(b)
(35,135
)
(298,647
)
Sabre Corp.(b)
(66,795
)
(213,744
)
SJM Holdings Ltd.(b)
(364,000
)
(125,169
)
Soho House & Co., Inc., Class A(b)
(25,499
)
(135,400
)
Total
(8,668,444
)
Household Durables (1.0)%
KB Home
(3,094
)
(242,879
)
Lennar Corp., Class A
(7,379
)
(1,256,644
)
LGI Homes, Inc.(b)
(4,840
)
(491,550
)
Pultegroup, Inc.
(5,524
)
(715,524
)
Total
(2,706,597
)
Leisure Products (0.1)%
Acushnet Holdings Corp.
(4,747
)
(290,991
)
Specialty Retail (0.4)%
Floor & Decor Holdings, Inc., Class A(b)
(5,708
)
(588,209
)
Lowe’s Companies, Inc.
(652
)
(170,713
)
Revolve Group, Inc.(b)
(8,335
)
(206,875
)
Tractor Supply Co.
(778
)
(206,567
)
Total
(1,172,364
)
Textiles, Apparel & Luxury Goods (0.2)%
Birkenstock Holding PLC(b)
(2,803
)
(128,938
)
Canada Goose Holdings, Inc.(b)
(4,718
)
(46,331
)
Deckers Outdoor Corp.(b)
(1,670
)
(268,686
)
NIKE, Inc., Class B
(997
)
(76,899
)
Total
(520,854
)
Total Consumer Discretionary
(15,921,898
)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
Consumer Staples (0.9)%
Beverages (0.3)%
Celsius Holdings, Inc.(b)
(7,959
)
(239,406
)
Davide Campari-Milano NV
(19,827
)
(133,114
)
National Beverage Corp.
(8,141
)
(367,892
)
Treasury Wine Estates Ltd.
(28,420
)
(211,000
)
Total
(951,412
)
Food Products (0.3)%
Barry Callebaut AG, Registered Shares
(126
)
(220,990
)
Hormel Foods Corp.
(10,980
)
(335,439
)
TreeHouse Foods, Inc.(b)
(6,436
)
(234,142
)
Yakult Honsha Co., Ltd.
(4,500
)
(97,790
)
Total
(888,361
)
Household Products (0.3)%
Church & Dwight Co., Inc.
(2,452
)
(244,979
)
Clorox Co. (The)
(1,392
)
(220,702
)
Kimberly-Clark Corp.
(1,566
)
(210,126
)
Total
(675,807
)
Total Consumer Staples
(2,515,580
)
Energy (1.3)%
Energy Equipment & Services (0.1)%
Core Laboratories, Inc.
(13,358
)
(252,466
)
Oil, Gas & Consumable Fuels (1.2)%
Antero Resources Corp.(b)
(13,479
)
(348,836
)
Cameco Corp.
(2,700
)
(141,094
)
CVR Energy, Inc.
(13,994
)
(222,504
)
Energy Fuels, Inc.(b)
(82,100
)
(495,896
)
Matador Resources Co.
(6,535
)
(340,539
)
Neste OYJ
(49,656
)
(797,278
)
New Fortress Energy, Inc.
(26,158
)
(219,989
)
NextDecade Corp.(b)
(17,562
)
(102,562
)
Occidental Petroleum Corp.
(12,345
)
(618,608
)
Permian Resources Corp.
(8,752
)
(119,290
)
Total
(3,406,596
)
Total Energy
(3,659,062
)
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
11

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
Financials (4.3)%
Banks (2.3)%
Aozora Bank Ltd.
(18,900
)
(325,839
)
Bank of Hawaii Corp.
(9,325
)
(673,545
)
Commerce Bancshares, Inc.
(6,979
)
(436,188
)
Commonwealth Bank of Australia
(11,911
)
(1,110,992
)
Community Financial System, Inc.
(11,852
)
(724,631
)
Cullen/Frost Bankers, Inc.
(2,721
)
(346,519
)
CVB Financial Corp.
(13,201
)
(256,496
)
First Financial Bankshares, Inc.
(16,265
)
(587,817
)
Glacier Bancorp, Inc.
(16,721
)
(872,000
)
Hang Seng Bank Ltd.
(46,100
)
(563,904
)
Texas Capital Bancshares, Inc.(b)
(4,676
)
(359,818
)
United Bankshares, Inc.
(7,200
)
(271,296
)
Total
(6,529,045
)
Capital Markets (0.8)%
Ashmore Group PLC
(93,127
)
(254,702
)
Avanza Bank Holding AB
(9,106
)
(189,677
)
EQT AB
(37,455
)
(1,086,683
)
Moelis & Co., Class A
(5,182
)
(344,085
)
T Rowe Price Group, Inc.
(4,556
)
(500,522
)
Total
(2,375,669
)
Consumer Finance (0.1)%
Credit Acceptance Corp.(b)
(689
)
(292,825
)
Upstart Holdings, Inc.(b)
(3,230
)
(157,236
)
Total
(450,061
)
Financial Services (0.5)%
Edenred SE
(7,071
)
(228,695
)
Toast, Inc. Class A(b)
(26,194
)
(786,606
)
Washington H. Soul Pattinson & Co., Ltd.
(14,492
)
(317,567
)
Total
(1,332,868
)
Insurance (0.6)%
Arthur J Gallagher & Co.
(1,563
)
(439,516
)
Cincinnati Financial Corp.
(2,052
)
(288,983
)
Erie Indemnity Co., Class A
(539
)
(241,925
)
Kinsale Capital Group, Inc.
(662
)
(283,409
)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
RLI Corp.
(1,285
)
(200,421
)
Trupanion, Inc.(b)
(2,577
)
(141,168
)
Total
(1,595,422
)
Mortgage Real Estate Investment Trusts (REITS) (0.0)%
Blackstone Mortgage Trust, Inc., Class A
(3,242
)
(59,037
)
Total Financials
(12,342,102
)
Health Care (5.6)%
Biotechnology (1.4)%
Ascendis Pharma A/S ADR(b)
(1,128
)
(138,541
)
Exact Sciences Corp.(b)
(9,378
)
(646,425
)
GRAIL, Inc.(b)
(4,518
)
(61,309
)
Legend Biotech Corp., ADR(b)
(2,953
)
(132,944
)
Madrigal Pharmaceuticals, Inc.(b)
(614
)
(159,235
)
Moderna, Inc.(b)
(15,406
)
(837,470
)
Myriad Genetics, Inc.(b)
(8,483
)
(186,287
)
Recursion Pharmaceuticals, Inc., Class A(b)
(14,357
)
(90,736
)
Rhythm Pharmaceuticals, Inc.(b)
(3,062
)
(146,149
)
TG Therapeutics, Inc.(b)
(5,480
)
(137,329
)
Twist Bioscience Corp.(b)
(3,828
)
(154,498
)
Vericel Corp.(b)
(22,249
)
(979,846
)
Zealand Pharma A/S(b)
(1,875
)
(216,455
)
Total
(3,887,224
)
Health Care Equipment & Supplies (1.0)%
Align Technology, Inc.(b)
(513
)
(105,180
)
Ambu A/S(b)
(6,707
)
(124,458
)
Carl Zeiss Meditec AG
(1,749
)
(110,103
)
Dexcom, Inc.(b)
(1,844
)
(129,965
)
Edwards Lifesciences Corp.(b)
(1,949
)
(130,603
)
Inspire Medical Systems, Inc.(b)
(6,478
)
(1,263,469
)
Neogen Corp.(b)
(7,534
)
(107,586
)
Zimmer Biomet Holdings, Inc.
(9,264
)
(990,507
)
Total
(2,961,871
)
Health Care Providers & Services (0.1)%
Guardant Health, Inc.(b)
(4,507
)
(98,613
)
Privia Health Group, Inc.(b)
(7,286
)
(133,771
)
Total
(232,384
)
The accompanying Notes to Financial Statements are an integral part of this statement.
12
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
Health Care Technology (0.2)%
GoodRx Holdings, Inc., Class A(b)
(21,396
)
(130,944
)
M3, Inc.
(42,500
)
(436,795
)
Schrodinger, Inc.(b)
(8,199
)
(144,261
)
Total
(712,000
)
Life Sciences Tools & Services (2.4)%
10X Genomics, Inc., Class A(b)
(7,067
)
(113,284
)
Charles River Laboratories International, Inc.(b)
(14,540
)
(2,596,553
)
Medpace Holdings, Inc.(b)
(8,181
)
(2,570,634
)
Oxford Nanopore Technologies PLC(b)
(120,111
)
(208,310
)
Sartorius AG
(600
)
(155,434
)
Sartorius Stedim Biotech
(5,577
)
(1,118,762
)
Total
(6,762,977
)
Pharmaceuticals (0.5)%
Astellas Pharma, Inc.
(39,000
)
(456,625
)
Cassava Sciences, Inc.(b)
(3,959
)
(102,162
)
Corcept Therapeutics, Inc.(b)
(2,971
)
(145,490
)
Eisai Co., Ltd.
(6,500
)
(220,221
)
Eyepoint Pharmaceuticals, Inc.(b)
(37,247
)
(438,024
)
Liquidia Corp.(b)
(1,408
)
(15,277
)
Pliant Therapeutics, Inc.(b)
(11,184
)
(157,359
)
Total
(1,535,158
)
Total Health Care
(16,091,614
)
Industrials (6.6)%
Aerospace & Defense (1.4)%
Archer Aviation, Inc., Class A(b)
(79,599
)
(250,737
)
Axon Enterprise, Inc.(b)
(5,200
)
(2,202,200
)
Boeing Co. (The)(b)
(5,969
)
(891,231
)
CAE, Inc.(b)
(3,500
)
(61,587
)
Northrop Grumman Corp.
(633
)
(322,210
)
Saab AB, Class B
(9,895
)
(203,231
)
Total
(3,931,196
)
Building Products (0.4)%
Nibe Industrier AB, Class B
(142,455
)
(690,699
)
Trex Co., Inc.(b)
(5,674
)
(402,003
)
Total
(1,092,702
)
Commercial Services & Supplies (0.1)%
Montrose Environmental Group, Inc.(b)
(13,088
)
(345,131
)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
Construction & Engineering (0.2)%
Thyssenkrupp Nucera AG & Co. KGaa(b),(g)
(48,233
)
(499,175
)
Electrical Equipment (1.5)%
Ballard Power Systems, Inc.(b)
(15,500
)
(24,602
)
ChargePoint Holdings, Inc.(b)
(67,113
)
(80,535
)
Enovix Corp.(b)
(23,751
)
(213,878
)
Furukawa Electric Co., Ltd.
(26,300
)
(646,821
)
NEXTracker, Inc., Class A(b)
(38,767
)
(1,543,702
)
Nidec Corp.
(12,200
)
(243,034
)
Plug Power, Inc.(b)
(71,527
)
(140,193
)
Rockwell Automation, Inc.
(5,563
)
(1,483,708
)
Total
(4,376,473
)
Machinery (0.7)%
Husqvarna AB
(70,240
)
(453,628
)
Kornit Digital Ltd.(b)
(14,715
)
(336,827
)
Proto Labs, Inc.(b)
(13,727
)
(376,120
)
Toro Co. (The)
(3,411
)
(274,517
)
VAT Group AG
(1,317
)
(548,391
)
Total
(1,989,483
)
Passenger Airlines (0.0)%
Joby Aviation, Inc.(b)
(21,198
)
(101,750
)
Professional Services (0.5)%
Dayforce, Inc.(b)
(9,893
)
(701,908
)
Dun & Bradstreet Holdings, Inc.
(18,254
)
(217,040
)
Exponent, Inc.
(4,039
)
(381,201
)
TransUnion
(615
)
(62,300
)
Total
(1,362,449
)
Trading Companies & Distributors (1.7)%
Ashtead Group PLC
(11,803
)
(882,955
)
Fastenal Co.
(5,163
)
(403,643
)
SiteOne Landscape Supply, Inc.(b)
(2,606
)
(364,162
)
Watsco, Inc.
(6,487
)
(3,068,416
)
Total
(4,719,176
)
Transportation Infrastructure (0.1)%
Atlas Arteria Ltd.
(132,667
)
(424,697
)
Total Industrials
(18,842,232
)
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
13

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
Information Technology (17.4)%
Communications Equipment (0.4)%
Ciena Corp.(b)
(18,429
)
(1,170,426
)
Electronic Equipment, Instruments & Components (1.5)%
CDW Corp.
(12,043
)
(2,266,854
)
Cognex Corp.
(9,726
)
(391,277
)
Evolv Technologies Holdings, Inc.(b)
(23,886
)
(51,355
)
Keysight Technologies, Inc.(b)
(5,579
)
(831,327
)
Lightwave Logic, Inc.(b)
(84,707
)
(266,827
)
Novanta, Inc.(b)
(2,606
)
(443,645
)
Total
(4,251,285
)
IT Services (2.2)%
Amdocs Ltd.
(3,295
)
(289,120
)
Applied Digital Corp.(b)
(9,708
)
(65,626
)
Cognizant Technology Solutions Corp., Class A
(29,649
)
(2,211,519
)
Infosys Ltd., ADR
(11,144
)
(233,021
)
International Business Machines Corp.
(10,136
)
(2,095,314
)
MongoDB, Inc.(b)
(2,823
)
(763,339
)
Snowflake, Inc., Class A(b)
(4,232
)
(485,918
)
Wix.com Ltd.(b)
(1,852
)
(309,506
)
Total
(6,453,363
)
Semiconductors & Semiconductor Equipment (9.2)%
Advanced Micro Devices, Inc.(b)
(17,595
)
(2,534,912
)
Applied Materials, Inc.
(11,600
)
(2,106,328
)
Axcelis Technologies, Inc.(b)
(16,587
)
(1,415,037
)
Enphase Energy, Inc.(b)
(5,964
)
(495,251
)
Entegris, Inc.
(25,350
)
(2,654,398
)
FormFactor, Inc.(b)
(49,923
)
(1,896,076
)
Kla-tencor Corporation
(3,878
)
(2,583,640
)
Lattice Semiconductor Corp.(b)
(22,317
)
(1,130,579
)
Microchip Technology, Inc.
(48,002
)
(3,521,907
)
Monolithic Power Systems, Inc.
(3,095
)
(2,350,033
)
Power Integrations, Inc.
(4,270
)
(258,036
)
Skyworks Solutions, Inc.
(15,771
)
(1,381,224
)
Teradyne, Inc.
(12,944
)
(1,374,782
)
Texas Instruments, Inc.
(12,013
)
(2,440,561
)
Wolfspeed, Inc.(b)
(7,250
)
(96,498
)
Total
(26,239,262
)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
Software (3.9)%
Atlassian Corp., Class A(b)
(13,371
)
(2,520,968
)
Blackline, Inc.(b)
(6,733
)
(372,806
)
Fortinet, Inc.(b)
(22,236
)
(1,749,084
)
Intuit, Inc.
(665
)
(405,850
)
Manhattan Associates, Inc.(b)
(6,426
)
(1,692,351
)
Palantir Technologies, Inc., Class A(b)
(9,357
)
(388,877
)
Procore Technologies, Inc.(b)
(57,537
)
(3,777,304
)
Samsara, Inc., Class A(b)
(6,044
)
(288,843
)
Total
(11,196,083
)
Technology Hardware, Storage & Peripherals (0.2)%
IonQ, Inc.(b)
(37,233
)
(559,612
)
Total Information Technology
(49,870,031
)
Materials (2.3)%
Chemicals (0.6)%
Albemarle Corp.
(5,774
)
(546,971
)
Axalta Coating Systems Ltd.(b)
(2,678
)
(101,550
)
Ganfeng Lithium Group Co., Ltd., Class H
(28,200
)
(77,362
)
Huntsman Corp.
(9,955
)
(219,010
)
OCI NV(b)
(31,943
)
(388,909
)
PureCycle Technologies, Inc.(b)
(18,265
)
(237,810
)
Sumitomo Chemical Co., Ltd.
(86,600
)
(231,200
)
Total
(1,802,812
)
Construction Materials (0.1)%
Summit Materials, Inc., Class A(b)
(7,899
)
(374,492
)
Containers & Packaging (0.1)%
Amcor PLC
(10,151
)
(112,981
)
Metals & Mining (1.5)%
Boliden AB
(13,090
)
(409,509
)
Compass Minerals International, Inc.
(4,046
)
(49,806
)
De Grey Mining Ltd.(b)
(600,297
)
(597,581
)
First Quantum Minerals Ltd.(b)
(43,700
)
(564,630
)
Ivanhoe Mines Ltd., Class A(b)
(9,200
)
(121,645
)
Liontown Resources Ltd.(b)
(491,744
)
(262,710
)
Lithium Americas Corp.(b)
(125,257
)
(509,178
)
Lynas Rare Earths Ltd.(b)
(130,545
)
(648,778
)
The accompanying Notes to Financial Statements are an integral part of this statement.
14
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
 
Common Stocks (continued)
Issuer
Shares
Value ($)
MP Materials Corp.(b)
(32,259
)
(580,339
)
Ryerson Holding Corp.
(20,708
)
(451,227
)
Total
(4,195,403
)
Total Materials
(6,485,688
)
Real Estate (0.7)%
Diversified REITs (0.0)%
Nomura Real Estate Master Fund, Inc.
(93
)
(87,794
)
Industrial REITs (0.0)%
Segro PLC
(8,136
)
(82,437
)
Office REITs (0.2)%
SL Green Realty Corp.
(5,962
)
(450,787
)
Real Estate Management & Development (0.4)%
CoStar Group, Inc.(b)
(6,061
)
(441,180
)
Sagax AB, Class B
(8,374
)
(201,804
)
Zillow Group, Inc., Class C(b)
(8,414
)
(505,597
)
Total
(1,148,581
)
Residential REITs (0.0)%
Mid-America Apartment Communities, Inc.
(648
)
(98,068
)
Retail REITs (0.1)%
Unibail-Rodamco-Westfield
(1,962
)
(160,437
)
Specialized REITs (0.0)%
Digital Realty Trust, Inc.
(719
)
(128,147
)
Total Real Estate
(2,156,251
)
Total Common Stocks
(Proceeds $134,627,708)
(131,059,900
)
 
Preferred Stocks (0.1)%
Issuer
 
Shares
Value ($)
Consumer Discretionary (0.1)%
Automobiles (0.1)%
Dr. Ing. h.c. F. Porsche AG
(6,181
)
(434,898
)
Total Consumer Discretionary
(434,898
)
Total Preferred Stocks
(Proceeds $526,022)
(434,898
)
 
Exchange-Traded Equity Funds (4.4)%
 
Shares
Value ($)
U.S. Large Cap (0.7)%
SPDR S&P 500 ETF Trust
(3,686
)
(2,096,007
)
U.S. Mid Large Cap (3.7)%
VanEck Vectors Semiconductor ETF
(6,463
)
(1,561,978
)
iShares MSCI USA Momentum Factor ETF
(44,066
)
(8,919,399
)
Total
(10,481,377
)
Total Exchange-Traded Equity Funds
(Proceeds $12,814,317)
(12,577,384
)
Total Investments in Securities Sold Short
(Proceeds $147,968,047)
(144,072,182
)
Total Investments in Securities, Net of Securities Sold Short
138,856,462
Other Assets & Liabilities, Net
147,415,621
Net Assets
286,272,083
At October 31, 2024, securities and/or cash totaling $269,449,636 were pledged as collateral.
Investments in derivatives 
Call option contracts purchased
Description
Counterparty
Trading
currency
Notional
amount
Number of
contracts
Exercise
price/Rate
Expiration
date
Cost ($)
Value ($)
Advanced Micro Devices, Inc.
Morgan Stanley
USD
2,521,225
175
167.50
11/01/2024
86,763
788
Amazon.com, Inc.
Morgan Stanley
USD
3,448,400
185
197.50
11/15/2024
92,344
73,537
Argenx SE
Morgan Stanley
USD
1,641,640
28
560.00
11/15/2024
54,193
96,460
Ascendis Pharma A/S
Morgan Stanley
USD
564,972
46
135.00
04/17/2025
56,719
43,930
Atlassian Corp.
Morgan Stanley
USD
2,262,480
120
195.00
11/01/2024
129,890
109,200
CDW Corp.
Morgan Stanley
USD
2,258,760
120
230.00
11/15/2024
60,229
1,200
Charles River Laboratories International
Morgan Stanley
USD
1,982,238
111
210.00
11/15/2024
68,046
22,200
Charles River Laboratories International
Morgan Stanley
USD
500,024
28
190.00
11/15/2024
24,617
15,540
Cognizant Technology Solutions Corp.
Morgan Stanley
USD
1,648,439
221
80.00
11/15/2024
22,807
8,840
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
15

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Call option contracts purchased (continued)
Description
Counterparty
Trading
currency
Notional
amount
Number of
contracts
Exercise
price/Rate
Expiration
date
Cost ($)
Value ($)
CommVault Systems, Inc.
Morgan Stanley
USD
1,436,948
92
150.00
11/15/2024
32,146
81,880
Enphase Energy, Inc.
Morgan Stanley
USD
921,744
111
120.00
11/15/2024
128,490
1,776
FormFactor, Inc.
Morgan Stanley
USD
349,416
92
45.00
11/15/2024
26,039
3,220
FormFactor, Inc.
Morgan Stanley
USD
1,052,046
277
50.00
11/15/2024
35,464
693
Inspire Medical Systems, Inc.
Morgan Stanley
USD
1,248,256
64
200.00
11/15/2024
90,607
96,640
International Business Machines Corp.
Morgan Stanley
USD
950,912
46
210.00
11/08/2024
9,077
7,360
iShares Russell 2000 ETF
Morgan Stanley
USD
4,028,560
185
225.00
11/15/2024
75,311
53,835
MediaAlpha, Inc.
Morgan Stanley
USD
171,300
100
22.50
11/15/2024
13,086
250
Medpace Holdings, Inc.
Morgan Stanley
USD
2,608,026
83
390.00
11/15/2024
99,689
4,150
Medpace Holdings, Inc.
Morgan Stanley
USD
408,486
13
380.00
11/15/2024
24,260
1,397
Microsoft Corp.
Morgan Stanley
USD
1,503,495
37
440.00
11/01/2024
28,105
130
Modine Manufacturing Co.
Morgan Stanley
USD
1,295,470
110
140.00
11/15/2024
70,069
12,650
Monolithic Power Systems, Inc.
Morgan Stanley
USD
1,670,460
22
950.00
11/15/2024
91,132
4,730
Morgan Stanley
Morgan Stanley
USD
3,220,125
277
120.00
11/15/2024
61,535
44,597
Natera, Inc.
Morgan Stanley
USD
1,112,832
92
125.00
11/15/2024
65,867
63,940
NEXTracker, Inc.
Morgan Stanley
USD
1,099,032
276
35.00
11/15/2024
51,686
155,940
NEXTracker, Inc.
Morgan Stanley
USD
438,020
110
40.00
11/15/2024
25,957
29,150
Pagaya Technologies Ltd.
Morgan Stanley
USD
851,328
739
11.00
11/15/2024
98,308
73,900
PROCEPT BioRobotics Corp.
Morgan Stanley
USD
1,161,000
129
70.00
11/15/2024
71,152
256,065
Procore Technologies, Inc.
Morgan Stanley
USD
2,415,920
368
65.00
11/15/2024
104,139
90,160
Procore Technologies, Inc.
Morgan Stanley
USD
603,980
92
70.00
11/15/2024
16,895
6,210
Reddit, Inc.
Morgan Stanley
USD
334,040
28
88.00
11/01/2024
7,898
79,030
Roku, Inc.
Morgan Stanley
USD
474,192
74
80.00
11/01/2024
18,623
40,330
Roku, Inc.
Morgan Stanley
USD
589,536
92
85.00
11/01/2024
26,461
46
RxSight, Inc.
Morgan Stanley
USD
932,144
184
50.00
11/15/2024
54,272
93,840
SharkNinja, Inc.
Morgan Stanley
USD
1,364,708
148
115.00
11/15/2024
83,404
2,960
SPDR S&P Regional Banking ETF
Morgan Stanley
USD
3,053,610
518
57.00
12/20/2024
145,018
255,115
State Street Bank and Trust Co.
Morgan Stanley
USD
7,598,655
1,289
61.00
11/08/2024
183,397
152,746
Taiwan Semiconductor Manufacturing Co., Ltd.
Morgan Stanley
USD
1,752,968
92
200.00
11/08/2024
35,349
21,988
Taiwan Semiconductor Manufacturing Co., Ltd.
Morgan Stanley
USD
3,544,044
186
180.00
11/15/2024
155,342
260,400
TransMedics Group, Inc.
Morgan Stanley
USD
368,865
45
140.00
11/15/2024
58,405
338
Uber Technologies, Inc.
Morgan Stanley
USD
1,995,785
277
82.00
11/08/2024
76,457
2,216
Upstart Holdings, Inc.
Morgan Stanley
USD
447,856
92
60.00
11/08/2024
35,517
17,664
Watsco, Inc.
Morgan Stanley
USD
2,175,846
46
510.00
11/15/2024
67,482
11,155
Watsco, Inc.
Morgan Stanley
USD
425,709
9
500.00
11/15/2024
16,792
4,050
Zeta Global Holdings Corp.
Morgan Stanley
USD
763,968
276
30.00
11/15/2024
86,421
63,480
Total
 
 
2,865,460
2,365,726
 
Put option contracts purchased
Description
Counterparty
Trading
currency
Notional
amount
Number of
contracts
Exercise
price/Rate
Expiration
date
Cost ($)
Value ($)
Albemarle Corp.
Morgan Stanley
USD
2,624,021
277
95.00
11/15/2024
162,471
171,047
Amazon.com, Inc.
Morgan Stanley
USD
2,479,120
133
182.50
11/08/2024
72,147
77,472
Apple, Inc.
Morgan Stanley
USD
2,485,010
110
230.00
11/01/2024
37,577
66,825
Apple, Inc.
Morgan Stanley
USD
2,485,010
110
225.00
11/08/2024
44,159
60,500
Applied Materials, Inc.
Morgan Stanley
USD
2,687,384
148
180.00
11/15/2024
122,541
115,440
Argenx SE
Morgan Stanley
USD
1,641,640
28
510.00
11/15/2024
19,504
6,930
Carvana Co.
Morgan Stanley
USD
766,661
31
190.00
11/08/2024
19,708
558
CDW Corp.
Morgan Stanley
USD
1,392,902
74
210.00
11/15/2024
33,211
157,250
Cellebrite DI Ltd.
Morgan Stanley
USD
604,395
333
17.50
11/15/2024
33,260
34,133
Champion Homes, Inc.
Morgan Stanley
USD
1,791,069
203
85.00
11/15/2024
68,461
57,347
CommVault Systems, Inc.
Morgan Stanley
USD
2,014,851
129
120.00
11/15/2024
45,461
4,838
Eli Lilly & Co.
Morgan Stanley
USD
2,572,194
31
815.00
11/08/2024
44,531
36,115
Eli Lilly & Co.
Morgan Stanley
USD
2,323,272
28
770.00
11/08/2024
49,995
6,244
Enphase Energy, Inc.
Morgan Stanley
USD
1,228,992
148
75.00
11/08/2024
37,889
18,278
Financial Select Sector SPDR Fund
Morgan Stanley
USD
8,556,968
1,841
46.00
11/08/2024
90,261
108,619
First Solar, Inc.
Morgan Stanley
USD
3,578,432
184
190.00
11/01/2024
108,197
16,284
The accompanying Notes to Financial Statements are an integral part of this statement.
16
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Put option contracts purchased (continued)
Description
Counterparty
Trading
currency
Notional
amount
Number of
contracts
Exercise
price/Rate
Expiration
date
Cost ($)
Value ($)
Floor & Decor Holdings, Inc.
Morgan Stanley
USD
1,906,425
185
105.00
11/15/2024
74,521
102,675
GeneDx Holdings Corp.
Morgan Stanley
USD
2,556,897
313
52.50
11/15/2024
137,188
14,085
Invesco QQQ Trust Series 1
Morgan Stanley
USD
10,257,620
212
490.00
11/01/2024
140,013
34,980
Invesco QQQ Trust Series 1
Morgan Stanley
USD
8,031,910
166
491.00
11/01/2024
121,356
30,959
KLA Corp.
Morgan Stanley
USD
1,865,444
28
680.00
11/15/2024
98,931
85,680
Lennar Corp.
Morgan Stanley
USD
3,150,550
185
180.00
11/08/2024
98,532
197,025
Modine Manufacturing Co.
Morgan Stanley
USD
1,295,470
110
110.00
11/15/2024
35,378
39,050
Monday.com Ltd.
Morgan Stanley
USD
4,878,242
166
270.00
11/15/2024
257,965
169,320
Monday.com Ltd.
Morgan Stanley
USD
1,087,319
37
280.00
11/15/2024
63,568
51,800
NEXTracker, Inc.
Morgan Stanley
USD
1,027,356
258
30.00
11/15/2024
57,637
4,515
Primoris Services Corp.
Morgan Stanley
USD
1,139,684
182
60.00
11/15/2024
35,530
43,225
PROCEPT BioRobotics Corp.
Morgan Stanley
USD
1,989,000
221
60.00
11/15/2024
61,367
1,105
Reddit, Inc.
Morgan Stanley
USD
7,706,780
646
75.00
11/01/2024
163,482
323
Reddit, Inc.
Morgan Stanley
USD
3,304,610
277
80.00
11/01/2024
132,120
139
Samsara, Inc.
Morgan Stanley
USD
2,207,898
462
48.00
11/08/2024
73,009
77,385
Samsara, Inc.
Morgan Stanley
USD
707,292
148
47.00
11/08/2024
25,309
22,940
SharkNinja, Inc.
Morgan Stanley
USD
2,037,841
221
95.00
11/15/2024
43,693
141,440
SharkNinja, Inc.
Morgan Stanley
USD
1,189,509
129
90.00
11/15/2024
50,019
44,505
Silicon Motion Technology Corp.
Morgan Stanley
USD
2,141,638
398
52.50
11/15/2024
53,025
79,600
Spotify Technology SA
Morgan Stanley
USD
2,849,740
74
365.00
11/15/2024
93,352
89,725
Super Micro Computer, Inc.
Morgan Stanley
USD
1,074,159
369
30.00
11/15/2024
85,917
169,740
TopBuild Corp.
Morgan Stanley
USD
1,307,506
37
370.00
11/15/2024
70,209
96,015
Universal Display Corp.
Morgan Stanley
USD
1,334,368
74
200.00
11/15/2024
58,195
145,040
Zeta Global Holdings Corp.
Morgan Stanley
USD
1,021,392
369
22.50
11/15/2024
32,010
41,513
Total
 
 
3,051,699
2,620,664
 
Call option contracts written
Description
Counterparty
Trading
currency
Notional
amount
Number of
contracts
Exercise
price/Rate
Expiration
date
Premium
received ($)
Value ($)
Advanced Micro Devices, Inc.
Morgan Stanley
USD
(1,599,177
)
(111
)
180.00
11/01/2024
(17,368
)
(167
)
Argenx SE
Morgan Stanley
USD
(1,641,640
)
(28
)
610.00
11/15/2024
(7,474
)
(22,260
)
Eli Lilly & Co.
Morgan Stanley
USD
(5,310,336
)
(64
)
1,000.00
11/01/2024
(47,414
)
(96
)
GeneDx Holdings Corp.
Morgan Stanley
USD
(449,295
)
(55
)
115.00
12/20/2024
(18,095
)
(16,500
)
GeneDx Holdings Corp.
Morgan Stanley
USD
(359,436
)
(44
)
90.00
12/20/2024
(9,602
)
(35,860
)
Monday.com Ltd.
Morgan Stanley
USD
(1,087,319
)
(37
)
310.00
11/01/2024
(6,038
)
(3,977
)
Monday.com Ltd.
Morgan Stanley
USD
(3,967,245
)
(135
)
305.00
11/01/2024
(62,067
)
(30,375
)
PROCEPT BioRobotics Corp.
Morgan Stanley
USD
(1,161,000
)
(129
)
90.00
12/20/2024
(21,594
)
(92,235
)
Procore Technologies, Inc.
Morgan Stanley
USD
(1,811,940
)
(276
)
75.00
11/15/2024
(13,516
)
(12,420
)
Samsara, Inc.
Morgan Stanley
USD
(2,207,898
)
(462
)
52.00
11/01/2024
(22,624
)
(5,775
)
SharkNinja, Inc.
Morgan Stanley
USD
(1,364,708
)
(148
)
130.00
11/15/2024
(20,193
)
(370
)
SPDR S&P Regional Banking ETF
Morgan Stanley
USD
(7,598,655
)
(1,289
)
65.00
11/08/2024
(43,067
)
(38,670
)
TransMedics Group, Inc.
Morgan Stanley
USD
(450,835
)
(55
)
180.00
11/15/2024
(16,061
)
(275
)
Watsco, Inc.
Morgan Stanley
USD
(425,709
)
(9
)
550.00
11/15/2024
(2,998
)
(743
)
Watsco, Inc.
Morgan Stanley
USD
(2,175,846
)
(46
)
560.00
11/15/2024
(11,479
)
(4,140
)
Total
 
 
(319,590
)
(263,863
)
 
Put option contracts written
Description
Counterparty
Trading
currency
Notional
amount
Number of
contracts
Exercise
price/Rate
Expiration
date
Premium
received ($)
Value ($)
Apple, Inc.
Morgan Stanley
USD
(2,485,010
)
(110
)
205.00
11/08/2024
(4,470
)
(7,205
)
Argenx SE
Morgan Stanley
USD
(1,641,640
)
(28
)
480.00
11/15/2024
(4,883
)
(7,000
)
Super Micro Computer, Inc.
Morgan Stanley
USD
(1,074,159
)
(369
)
20.00
11/15/2024
(14,801
)
(43,357
)
Total
 
 
(24,154
)
(57,562
)
 
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
17

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Total return swap contracts
Fund receives
Fund pays
Payment
frequency
Counterparty
Maturity
date
Notional
currency
Notional
amount
Value
($)
Periodic
payments
receivable
(payable)
($)
Upfront
payments
($)
Upfront
receipts
($)
Unrealized
appreciation
($)
Unrealized
depreciation
($)
Total return on
GeneDx Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
853,718
308,813
(2,042
)
306,771
Total return on
GeneDx Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
806,925
291,887
(1,930
)
289,957
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,167,752
143,749
(2,618
)
141,131
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,167,065
143,665
(2,617
)
141,048
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,161,567
142,988
(2,606
)
140,382
Total return on
CommVault
Systems, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
2,173,248
122,745
(4,873
)
117,872
Total return on
argenx SE
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,507,926
117,298
(3,155
)
114,143
Total return on
CommVault
Systems, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
2,026,147
114,437
(4,543
)
109,894
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
589,092
72,517
(1,322
)
71,195
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
587,655
72,340
(1,318
)
71,022
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
581,721
71,609
(1,304
)
70,305
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
573,225
70,563
(1,285
)
69,278
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
548,986
67,580
(1,231
)
66,349
Total return on
Primoris Services
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,311,019
40,133
(2,939
)
37,194
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
292,547
36,012
(656
)
35,356
The accompanying Notes to Financial Statements are an integral part of this statement.
18
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Total return swap contracts (continued)
Fund receives
Fund pays
Payment
frequency
Counterparty
Maturity
date
Notional
currency
Notional
amount
Value
($)
Periodic
payments
receivable
(payable)
($)
Upfront
payments
($)
Upfront
receipts
($)
Unrealized
appreciation
($)
Unrealized
depreciation
($)
Total return on
Primoris Services
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
660,461
20,218
(1,480
)
18,738
Total return on
CommVault
Systems, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
282,670
15,965
(676
)
15,289
Total return on
CommVault
Systems, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
279,122
15,765
(626
)
15,139
Total return on
CommVault
Systems, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
264,338
14,930
(593
)
14,337
Total return on
Astera Labs, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
78,087
9,613
(187
)
9,426
Total return on
Taiwan
Semiconductor
Manufacturing Co.,
Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
511,239
9,316
(1,145
)
8,171
Total return on
CommVault
Systems, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
149,910
8,467
(336
)
8,131
Total return on
GeneDx Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
11,698
4,232
(28
)
4,204
Total return on
Taiwan
Semiconductor
Manufacturing Co.,
Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
256,929
4,682
(576
)
4,106
Total return on
CommVault
Systems, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
43,169
2,438
(104
)
2,334
Total return on
Taiwan
Semiconductor
Manufacturing Co.,
Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
113,962
2,076
(229
)
1,847
Total return on
Taiwan
Semiconductor
Manufacturing Co.,
Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
79,530
1,449
(178
)
1,271
Total return on
Taiwan
Semiconductor
Manufacturing Co.,
Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
71,297
1,299
(143
)
1,156
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
19

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Total return swap contracts (continued)
Fund receives
Fund pays
Payment
frequency
Counterparty
Maturity
date
Notional
currency
Notional
amount
Value
($)
Periodic
payments
receivable
(payable)
($)
Upfront
payments
($)
Upfront
receipts
($)
Unrealized
appreciation
($)
Unrealized
depreciation
($)
Total return on
Cellebrite DI Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
723,600
2,400
(1,622
)
778
Total return on
Cellebrite DI Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
279,617
927
(627
)
300
Total return on
Taiwan
Semiconductor
Manufacturing Co.,
Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
7,859
143
(17
)
126
Total return on
Cellebrite DI Ltd.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
6,096
20
(13
)
7
Total return on IES
Holdings, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
9,018
(52
)
(20
)
(72
)
Total return on IES
Holdings, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
14,736
(85
)
(36
)
(121
)
Total return on
Amazon.com, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
18,957
(130
)
(43
)
(173
)
Total return on
Champion Homes,
Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
3,943
(325
)
(10
)
(335
)
Total return on Axon
Enterprise, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
33,861
(828
)
(76
)
(904
)
Total return on Axon
Enterprise, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
50,358
(1,232
)
(113
)
(1,345
)
Total return on
Amazon.com, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
169,859
(1,167
)
(381
)
(1,548
)
Total return on IES
Holdings, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
194,427
(1,127
)
(465
)
(1,592
)
Total return on
Amazon.com, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
189,942
(1,305
)
(426
)
(1,731
)
Total return on
Silicon Motion
Technology Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
30,009
(1,813
)
(72
)
(1,885
)
Total return on
Amazon.com, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
272,151
(1,871
)
(610
)
(2,481
)
The accompanying Notes to Financial Statements are an integral part of this statement.
20
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Total return swap contracts (continued)
Fund receives
Fund pays
Payment
frequency
Counterparty
Maturity
date
Notional
currency
Notional
amount
Value
($)
Periodic
payments
receivable
(payable)
($)
Upfront
payments
($)
Upfront
receipts
($)
Unrealized
appreciation
($)
Unrealized
depreciation
($)
Total return on IES
Holdings, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
407,769
(2,364
)
(915
)
(3,279
)
Total return on
Insmed, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
34,045
(3,365
)
(77
)
(3,442
)
Total return on
Amazon.com, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
617,312
(4,243
)
(1,384
)
(5,627
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
40,477
(5,628
)
(90
)
(5,718
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
47,003
(6,535
)
(113
)
(6,648
)
Total return on
Natera, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
115,068
(7,172
)
(258
)
(7,430
)
Total return on Axon
Enterprise, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
294,767
(7,211
)
(661
)
(7,872
)
Total return on IES
Holdings, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,009,085
(5,850
)
(2,413
)
(8,263
)
Total return on Eli
Lilly & Co.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
88,592
(8,107
)
(199
)
(8,306
)
Total return on
Silicon Motion
Technology Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
134,756
(8,141
)
(302
)
(8,443
)
Total return on Axon
Enterprise, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
329,931
(8,071
)
(740
)
(8,811
)
Total return on
Silicon Motion
Technology Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
171,581
(10,366
)
(345
)
(10,711
)
Total return on
Amazon.com, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,217,357
(8,367
)
(2,729
)
(11,096
)
Total return on Axon
Enterprise, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
471,888
(11,544
)
(1,058
)
(12,602
)
Total return on
Champion Homes,
Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
174,627
(14,401
)
(417
)
(14,818
)
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
21

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Total return swap contracts (continued)
Fund receives
Fund pays
Payment
frequency
Counterparty
Maturity
date
Notional
currency
Notional
amount
Value
($)
Periodic
payments
receivable
(payable)
($)
Upfront
payments
($)
Upfront
receipts
($)
Unrealized
appreciation
($)
Unrealized
depreciation
($)
Total return on
CommVault
Systems, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,148,969
(18,621
)
(18,621
)
Total return on
Insmed, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
238,315
(23,557
)
(480
)
(24,037
)
Total return on Axon
Enterprise, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
998,910
(24,437
)
(2,238
)
(26,675
)
Total return on
Natera, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
416,670
(25,969
)
(839
)
(26,808
)
Total return on Axon
Enterprise, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,070,974
(26,200
)
(2,400
)
(28,600
)
Total return on
Insmed, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
285,575
(28,228
)
(683
)
(28,911
)
Total return on Eli
Lilly & Co.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
312,355
(28,584
)
(701
)
(29,285
)
Total return on
Natera, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
465,819
(29,032
)
(1,045
)
(30,077
)
Total return on Eli
Lilly & Co.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
348,888
(31,928
)
(782
)
(32,710
)
Total return on
Natera, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
588,756
(36,695
)
(1,320
)
(38,015
)
Total return on
Insmed, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
408,838
(40,413
)
(917
)
(41,330
)
Total return on
MongoDB, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
797,902
(39,971
)
(1,789
)
(41,760
)
Total return on
Natera, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
667,188
(41,583
)
(1,495
)
(43,078
)
Total return on Eli
Lilly & Co.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
498,673
(45,635
)
(1,118
)
(46,753
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
346,223
(48,137
)
(698
)
(48,835
)
The accompanying Notes to Financial Statements are an integral part of this statement.
22
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Total return swap contracts (continued)
Fund receives
Fund pays
Payment
frequency
Counterparty
Maturity
date
Notional
currency
Notional
amount
Value
($)
Periodic
payments
receivable
(payable)
($)
Upfront
payments
($)
Upfront
receipts
($)
Unrealized
appreciation
($)
Unrealized
depreciation
($)
Total return on
Insmed, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
489,247
(48,361
)
(1,097
)
(49,458
)
Total return on
MongoDB, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,004,280
(50,309
)
(2,252
)
(52,561
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
387,150
(53,828
)
(868
)
(54,696
)
Total return on
Silicon Motion
Technology Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
889,689
(53,751
)
(1,994
)
(55,745
)
Total return on
Silicon Motion
Technology Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,060,869
(64,093
)
(2,378
)
(66,471
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
536,648
(74,613
)
(1,203
)
(75,816
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
554,427
(77,085
)
(1,243
)
(78,328
)
Total return on Eli
Lilly & Co.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
841,168
(76,977
)
(1,886
)
(78,863
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
593,585
(82,530
)
(1,331
)
(83,861
)
Total return on
Natera, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,513,815
(94,349
)
(3,394
)
(97,743
)
Total return on Eli
Lilly & Co.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,133,430
(103,723
)
(2,541
)
(106,264
)
Total return on
Insmed, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,110,120
(109,733
)
(2,489
)
(112,222
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
909,170
(126,407
)
(2,039
)
(128,446
)
Total return on
Champion Homes,
Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,781,460
(146,911
)
(4,263
)
(151,174
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
1,257,933
(174,898
)
(2,820
)
(177,718
)
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
23

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Total return swap contracts (continued)
Fund receives
Fund pays
Payment
frequency
Counterparty
Maturity
date
Notional
currency
Notional
amount
Value
($)
Periodic
payments
receivable
(payable)
($)
Upfront
payments
($)
Upfront
receipts
($)
Unrealized
appreciation
($)
Unrealized
depreciation
($)
Total return on
Natera, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
2,927,010
(182,428
)
(6,561
)
(188,989
)
Total return on Eli
Lilly & Co.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
2,187,401
(200,174
)
(4,903
)
(205,077
)
Total return on
Insmed, Inc.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
2,188,733
(216,352
)
(4,906
)
(221,258
)
Total return on Zeta
Global Holdings
Corp.
1-Day Overnight Fed
Funds Effective
Rate plus 0.550%
Monthly
Morgan Stanley
07/24/2026
USD
2,480,180
(344,834
)
(5,560
)
(350,394
)
Total return on
AtkinsRealis
Group, Inc.
CORRA plus 0.550%
Monthly
Morgan Stanley
07/27/2026
CAD
2,058,330
111,526
(2,989
)
108,537
Total return on
AtkinsRealis
Group, Inc.
CORRA plus 0.550%
Monthly
Morgan Stanley
07/27/2026
CAD
1,062,651
57,577
(1,517
)
56,060
Total return on
AtkinsRealis
Group, Inc.
CORRA plus 0.550%
Monthly
Morgan Stanley
07/27/2026
CAD
592,722
32,115
(903
)
31,212
Total return on
AtkinsRealis
Group, Inc.
CORRA plus 0.550%
Monthly
Morgan Stanley
07/27/2026
CAD
468,309
25,374
(668
)
24,706
Total return on
AtkinsRealis
Group, Inc.
CORRA plus 0.550%
Monthly
Morgan Stanley
07/27/2026
CAD
327,075
17,722
(467
)
17,255
Total return on
AtkinsRealis
Group, Inc.
CORRA plus 0.550%
Monthly
Morgan Stanley
07/27/2026
CAD
292,436
15,845
(418
)
15,427
Total return on
AtkinsRealis
Group, Inc.
CORRA plus 0.550%
Monthly
Morgan Stanley
07/27/2026
CAD
69,402
3,760
(99
)
3,661
Total
 
 
 
 
 
(697,451
)
(134,266
)
2,144,115
(2,975,832
)
 
Reference index and values for swap contracts as of period end
Reference index
 
Reference rate
1-Day Overnight Fed Funds Effective Rate
Overnight Federal Funds Effective Rate
4.830%
CORRA
Canadian Overnight Repo Rate Average
3.810%
Notes to Portfolio of Investments 
(a)
This security or a portion of this security has been pledged as collateral in connection with investments sold short and/or derivative contracts.
(b)
Non-income producing investment.
(c)
Represents fair value as determined in good faith under procedures approved by the Board of Trustees. At October 31, 2024, the total value of these securities amounted to $0, which represents less than 0.01% of total net assets.
(d)
Valuation based on significant unobservable inputs.
(e)
The rate shown is the seven-day current annualized yield at October 31, 2024.
The accompanying Notes to Financial Statements are an integral part of this statement.
24
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Notes to Portfolio of Investments (continued)
(f)
As defined in the Investment Company Act of 1940, as amended, an affiliated company is one in which the Fund owns 5% or more of the company’s outstanding voting securities, or a company which is under common ownership or control with the Fund. The value of the holdings and transactions in these affiliated companies during the period ended October 31, 2024 are as follows:
 
Affiliated issuers
Beginning
of period($)
Purchases($)
Sales($)
Net change in
unrealized
appreciation
(depreciation)($)
End of
period($)
Realized gain
(loss)($)
Dividends($)
End of
period shares
Columbia Short-Term Cash Fund, 5.040%
 
49,547,895
123,171,961
(159,411,963
)
(3,022
)
13,304,871
9,504
886,739
13,307,533
 
(g)
Represents privately placed and other securities and instruments exempt from Securities and Exchange Commission registration (collectively, private placements), such as Section 4(a)(2) and Rule 144A eligible securities, which are often sold only to qualified institutional buyers. At October 31, 2024, the total value of these securities amounted to $499,175, which represents 0.17% of total net assets.
Abbreviation Legend 
ADR
American Depositary Receipt
Currency Legend 
CAD
Canada Dollar
USD
US Dollar
Fair value measurements  
The Fund categorizes its fair value measurements according to a three-level hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs by prioritizing that the most observable input be used when available. Observable inputs are those that market participants would use in pricing an investment based on market data obtained from sources independent of the reporting entity. Unobservable inputs are those that reflect the Fund’s assumptions about the information market participants would use in pricing an investment. An investment’s level within the fair value hierarchy is based on the lowest level of any input that is deemed significant to the asset’s or liability’s fair value measurement. The input levels are not necessarily an indication of the risk or liquidity associated with investments at that level. For example, certain U.S. government securities are generally high quality and liquid, however, they are reflected as Level 2 because the inputs used to determine fair value may not always be quoted prices in an active market.
Fair value inputs are summarized in the three broad levels listed below:

 Level 1 — Valuations based on quoted prices for investments in active markets that the Fund has the ability to access at the measurement date.  Valuation adjustments are not applied to Level 1 investments.

 Level 2 — Valuations based on other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risks, etc.).

 Level 3 — Valuations based on significant unobservable inputs (including the Fund’s own assumptions and judgment in determining the fair value of investments).
Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments, and is affected by various factors such as the type of investment, and the volume and level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Investment Manager, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the measurement date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy.
Foreign equity securities actively traded in markets where there is a significant delay in the local close relative to the New York Stock Exchange are classified as Level 2. The values of these securities may include an adjustment to reflect the impact of market movements following the close of local trading, as described in Note 2 to the financial statements – Security valuation.
Investments falling into the Level 3 category, if any, are primarily supported by quoted prices from brokers and dealers participating in the market for those investments. However, these may be classified as Level 3 investments due to lack of market transparency and corroboration to support these quoted prices. Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Investment Manager. Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable company data.
The Fund’s Board of Trustees (the Board) has designated the Investment Manager, through its Valuation Committee (the Committee), as valuation designee, responsible for determining the fair value of the assets of the Fund for which market quotations are not readily available using valuation procedures approved by the Board. The Committee consists of voting and non-voting members from various groups within the Investment Manager’s organization, including operations and accounting, trading and investments, compliance, risk management and legal.
The Committee meets at least monthly to review and approve valuation matters, which may include a description of specific valuation determinations, data regarding pricing information received from approved pricing vendors and brokers and the results of Board-approved valuation policies and procedures (the Policies). The Policies address, among other things, instances when market quotations are or are not readily available, including recommendations of third party pricing vendors and a determination of appropriate pricing methodologies; events that require specific valuation determinations and assessment of fair value techniques; securities with a potential for stale pricing, including those that are illiquid, restricted, or
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
25

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Fair value measurements   (continued)
in default; and the effectiveness of third party pricing vendors, including periodic reviews of vendors. The Committee meets more frequently, as needed, to discuss additional valuation matters, which may include the need to review back-testing results, review time-sensitive information or approve related valuation actions. Representatives of Columbia Management Investment Advisers, LLC report to the Board at each of its regularly scheduled meetings to discuss valuation matters and actions during the period, similar to those described earlier.
The following table is a summary of the inputs used to value the Fund’s investments at October 31, 2024: 
 
Level 1 ($)
Level 2 ($)
Level 3 ($)
Total ($)
Investments in Securities
Common Stocks
Communication Services
29,363,225
1,907,263
31,270,488
Consumer Discretionary
17,849,998
1,325,047
19,175,045
Consumer Staples
7,213,823
2,587,408
9,801,231
Energy
5,634,306
2,058,394
7,692,700
Financials
25,924,402
7,339,220
33,263,622
Health Care
41,700,412
1,917,760
43,618,172
Industrials
30,224,892
8,794,375
39,019,267
Information Technology
48,685,472
1,045,591
49,731,063
Materials
8,652,381
1,905,226
10,557,607
Real Estate
5,392,893
5,392,893
Utilities
9,459,844
4,545,089
14,004,933
Total Common Stocks
230,101,648
33,425,373
263,527,021
Limited Partnerships
Energy
777,517
777,517
Total Limited Partnerships
777,517
777,517
Preferred Stocks
Consumer Discretionary
119,653
119,653
Consumer Staples
213,192
213,192
Total Preferred Stocks
332,845
332,845
Warrants
Information Technology
0
*
0
*
Total Warrants
0
*
0
*
Call Option Contracts Purchased
2,365,726
2,365,726
Put Option Contracts Purchased
2,620,664
2,620,664
Money Market Funds
13,304,871
13,304,871
Total Investments in Securities
249,170,426
33,758,218
0
*
282,928,644
Investments in Securities Sold Short
Common Stocks
Communication Services
(1,780,581
)
(1,394,861
)
(3,175,442
)
Consumer Discretionary
(14,555,982
)
(1,365,916
)
(15,921,898
)
Consumer Staples
(1,852,686
)
(662,894
)
(2,515,580
)
Energy
(2,861,784
)
(797,278
)
(3,659,062
)
Financials
(8,264,043
)
(4,078,059
)
(12,342,102
)
Health Care
(13,044,451
)
(3,047,163
)
(16,091,614
)
Industrials
(14,249,601
)
(4,592,631
)
(18,842,232
)
Information Technology
(49,870,031
)
(49,870,031
)
Materials
(3,869,639
)
(2,616,049
)
(6,485,688
)
Real Estate
(1,623,779
)
(532,472
)
(2,156,251
)
Total Common Stocks
(111,972,577
)
(19,087,323
)
(131,059,900
)
Exchange-Traded Equity Funds
(12,577,384
)
(12,577,384
)
Preferred Stocks
Consumer Discretionary
(434,898
)
(434,898
)
Total Preferred Stocks
(434,898
)
(434,898
)
Total Investments in Securities Sold Short
(124,549,961
)
(19,522,221
)
(144,072,182
)
Total Investments in Securities, Net of Securities Sold Short
124,620,465
14,235,997
0
*
138,856,462
Investments in Derivatives
Asset
Swap Contracts
2,144,115
2,144,115
The accompanying Notes to Financial Statements are an integral part of this statement.
26
Multi-Manager Directional Alternative Strategies Fund  | 2024

Portfolio of Investments (continued)
October 31, 2024 (Unaudited)
Fair value measurements   (continued)
 
Level 1 ($)
Level 2 ($)
Level 3 ($)
Total ($)
Liability
Call Option Contracts Written
(263,863
)
(263,863
)
Put Option Contracts Written
(57,562
)
(57,562
)
Swap Contracts
(2,975,832
)
(2,975,832
)
Total
124,299,040
13,404,280
0
*
137,703,320
 
*
Rounds to zero.
See the Portfolio of Investments for all investment classifications not indicated in the table.
The Fund’s assets assigned to the Level 2 input category are generally valued using the market approach, in which a security’s value is determined through reference to prices and information from market transactions for similar or identical assets. These assets include certain foreign securities for which a third party statistical pricing service may be employed for purposes of fair market valuation. The model utilized by such third party statistical pricing service takes into account a security’s correlation to available market data including, relevant general and sector indices, currency fluctuations, depositary receipts, and futures, as applicable.
Swap contracts are valued at unrealized appreciation (depreciation).
The Fund does not hold any significant investments (greater than one percent of net assets) categorized as Level 3.
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
27

Statement of Assets and Liabilities
October 31, 2024 (Unaudited)
 
Assets
Investments in securities, at value
Unaffiliated issuers (cost $216,975,784)
$264,637,383
Affiliated issuers (cost $13,303,742)
13,304,871
Option contracts purchased (cost $5,917,159)
4,986,390
Cash
126,560
Foreign currency (cost $1,534)
1,502
Cash collateral held at broker for:
Swap contracts
10,800,000
Other(a)
137,631,386
Unrealized appreciation on swap contracts
2,144,115
Receivable for:
Investments sold
1,606,978
Capital shares sold
105,554
Dividends
273,293
Interest
339,020
Foreign tax reclaims
251,633
Expense reimbursement due from Investment Manager
628
Prepaid expenses
3,754
Deferred compensation of board members
50,179
Other assets
111
Total assets
436,263,357
Liabilities
Securities sold short, at value (proceeds $147,968,047)
144,072,182
Option contracts written, at value (premiums received $343,744)
321,425
Unrealized depreciation on swap contracts
2,975,832
Payable for:
Investments purchased
1,534,792
Capital shares redeemed
292,171
Dividends and interest on securities sold short
600,026
Management services fees
12,656
Transfer agent fees
43,205
Compensation of chief compliance officer
25
Compensation of board members
742
Other expenses
64,884
Deferred compensation of board members
73,334
Total liabilities
149,991,274
Net assets applicable to outstanding capital stock
$286,272,083
Represented by
Paid in capital
222,045,328
Total distributable earnings (loss)
64,226,755
Total - representing net assets applicable to outstanding capital stock
$286,272,083
Institutional Class
Net assets
$286,272,083
Shares outstanding
36,658,399
Net asset value per share
$7.81
 
(a)
Includes collateral related to option contracts purchased, option contracts written, swap contracts and securities sold short.
The accompanying Notes to Financial Statements are an integral part of this statement.
28
Multi-Manager Directional Alternative Strategies Fund  | 2024

Statement of Operations
Six Months Ended October 31, 2024 (Unaudited)
 
Net investment income
Income:
Dividends — unaffiliated issuers
$2,211,953
Dividends — affiliated issuers
886,739
Interest
1,568,161
Interfund lending
65
Foreign taxes withheld
(87,077
)
Total income
4,579,841
Expenses:
Management services fees
2,225,728
Transfer agent fees
Institutional Class
277,618
Custodian fees
56,131
Printing and postage fees
31,355
Registration fees
20,440
Accounting services fees
26,443
Legal fees
6,595
Dividends and interest on securities sold short
1,152,677
Interest on interfund lending
146
Compensation of chief compliance officer
25
Compensation of board members
6,918
Deferred compensation of board members
2,918
Other
5,389
Total expenses
3,812,383
Fees waived or expenses reimbursed by Investment Manager and its affiliates
(282,722
)
Total net expenses
3,529,661
Net investment income
1,050,180
Realized and unrealized gain (loss) — net
Net realized gain (loss) on:
Investments — unaffiliated issuers
17,191,195
Investments — affiliated issuers
9,504
Foreign currency translations
(17,293
)
Option contracts purchased
(4,004,070
)
Option contracts written
(92,574
)
Securities sold short
(4,386,225
)
Swap contracts
6,364,353
Net realized gain
15,064,890
Net change in unrealized appreciation (depreciation) on:
Investments — unaffiliated issuers
12,546,863
Investments — affiliated issuers
(3,022
)
Foreign currency translations
242,226
Option contracts purchased
(930,769
)
Option contracts written
20,887
Securities sold short
(704,962
)
Swap contracts
(831,717
)
Net change in unrealized appreciation (depreciation)
10,339,506
Net realized and unrealized gain
25,404,396
Net increase in net assets resulting from operations
$26,454,576
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
29

Statement of Changes in Net Assets
 
 
Six Months Ended
October 31, 2024
(Unaudited)
Year Ended
April 30, 2024
Operations
Net investment income
$1,050,180
$3,937,217
Net realized gain
15,064,890
15,794,838
Net change in unrealized appreciation (depreciation)
10,339,506
11,654,699
Net increase in net assets resulting from operations
26,454,576
31,386,754
Distributions to shareholders
Net investment income and net realized gains
Institutional Class
(4,149,250
)
Total distributions to shareholders
(4,149,250
)
Decrease in net assets from capital stock activity
(12,763,783
)
(14,419,213
)
Total increase in net assets
13,690,793
12,818,291
Net assets at beginning of period
272,581,290
259,762,999
Net assets at end of period
$286,272,083
$272,581,290
 
 
Six Months Ended
Year Ended
 
October 31, 2024 (Unaudited)
April 30, 2024
 
Shares
Dollars ($)
Shares
Dollars ($)
Capital stock activity
Institutional Class
Shares sold
2,192,486
16,217,893
6,632,497
44,316,193
Distributions reinvested
617,448
4,149,250
Shares redeemed
(3,920,620
)
(28,981,676
)
(9,355,548
)
(62,884,656
)
Net decrease
(1,728,134
)
(12,763,783
)
(2,105,603
)
(14,419,213
)
Total net decrease
(1,728,134
)
(12,763,783
)
(2,105,603
)
(14,419,213
)
The accompanying Notes to Financial Statements are an integral part of this statement.
30
Multi-Manager Directional Alternative Strategies Fund  | 2024

Financial Highlights
The following table is intended to help you understand the Fund’s financial performance. Certain information reflects financial results for a single share of a class held for the periods shown. Per share net investment income (loss) amounts are calculated based on average shares outstanding during the period. Total return assumes reinvestment of all dividends and distributions, if any. Total return does not reflect payment of sales charges, if any. Total return and portfolio turnover are not annualized for periods of less than one year. The ratios of expenses and net investment income are annualized for periods of less than one year. The portfolio turnover rate is calculated without regard to purchase and sales transactions of short-term instruments and certain derivatives, if any. If such transactions were included, the Fund’s portfolio turnover rate may be higher.   
Institutional Class
Six Months Ended
October 31, 2024
(Unaudited)
Year Ended April 30,
2024
2023
2022
2021
2020
Per share data
Net asset value, beginning of period
$7.10
$6.42
$7.42
$7.23
$6.00
$6.78
Income (loss) from investment operations:
Net investment income (loss)
0.03
0.10
0.04
(0.07
)
(0.08
)
(0.01
)
Net realized and unrealized gain (loss)
0.68
0.69
(0.28
)
0.80
1.31
(0.72
)
Total from investment operations
0.71
0.79
(0.24
)
0.73
1.23
(0.73
)
Distributions to shareholders
Distributions from net investment income
(0.09
)
(0.15
)
(0.08
)
Distributions from net realized gains
(0.02
)
(0.61
)
(0.46
)
(0.05
)
Total distributions to shareholders
(0.11
)
(0.76
)
(0.54
)
(0.05
)
Net asset value, end of period
$7.81
$7.10
$6.42
$7.42
$7.23
$6.00
Total return
10.00
%
12.34
%
(3.44
%)
10.42
%
20.50
%
(10.81
%)
Ratios to average net assets
Total gross expenses(a)
2.73
%(b),(c)
2.36
%(b),(c)
2.62
%(b),(c)
2.61
%(b),(c),(d)
2.90
%(b),(c),(d)
2.31
%(b),(d)
Total net expenses(a),(e)
2.53
%(b),(c)
2.07
%(b),(c)
2.35
%(b),(c)
2.43
%(b),(c),(d)
2.71
%(b),(c),(d)
2.19
%(b),(d)
Net investment income (loss)
0.75
%
1.47
%
0.62
%
(1.00
%)
(1.31
%)
(0.14
%)
Supplemental data
Net assets, end of period (in thousands)
$286,272
$272,581
$259,763
$266,700
$278,350
$221,159
Portfolio turnover
127
%
193
%
399
%
323
%
254
%
197
%
 
Notes to Financial Highlights
(a)
In addition to the fees and expenses that the Fund bears directly, the Fund indirectly bears a pro rata share of the fees and expenses of any other funds in which it invests. Such indirect expenses are not included in the Fund’s reported expense ratios.
(b)
Ratios include dividends and interest on securities sold short. If dividends and interest on securities sold short had been excluded, annualized expenses would have been lower by:
 
Class
10/31/2024
4/30/2024
4/30/2023
4/30/2022
4/30/2021
4/30/2020
Institutional Class
0.83%
0.41%
0.51%
0.59%
0.87%
0.32%
 
(c)
Ratios include interfund lending expense which is less than 0.01%.
(d)
Ratios include interest on collateral expense which is less than 0.01%.
(e)
Total net expenses include the impact of certain fee waivers/expense reimbursements made by the Investment Manager and certain of its affiliates, if applicable.
The accompanying Notes to Financial Statements are an integral part of this statement.
Multi-Manager Directional Alternative Strategies Fund  | 2024
31

Notes to Financial Statements
October 31, 2024 (Unaudited)
Note 1. Organization
Multi-Manager Directional Alternative Strategies Fund (the Fund), a series of Columbia Funds Series Trust I (the Trust), is a diversified fund. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust.
Fund shares 
The Trust may issue an unlimited number of shares (without par value). The Fund is offered only through certain wrap fee programs sponsored and/or managed by Ameriprise Financial, Inc. (Ameriprise Financial) or its affiliates. The Fund offers the share class listed in the Statement of Assets and Liabilities which is not subject to any front-end sales charge or contingent deferred sales charge.
Note 2. Summary of significant accounting policies
Basis of preparation
The Fund is an investment company that applies the accounting and reporting guidance in the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946, Financial Services - Investment Companies (ASC 946). The financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.
The following is a summary of significant accounting policies followed by the Fund in the preparation of its financial statements.
Security valuation
Equity securities listed on an exchange are valued at the closing price or last trade price on their primary exchange at the close of business of the New York Stock Exchange. Securities with a closing price not readily available or not listed on any exchange are valued at the mean between the closing bid and ask prices. Listed preferred stocks convertible into common stocks are valued using an evaluated price from a pricing service.
Foreign equity securities are valued based on the closing price or last trade price on their primary exchange at the close of business of the New York Stock Exchange. If any foreign equity security closing prices are not readily available, the securities are valued at the mean of the latest quoted bid and ask prices on such exchanges or markets. Foreign currency exchange rates are determined at the scheduled closing time of the New York Stock Exchange. Many securities markets and exchanges outside the U.S. close prior to the close of the New York Stock Exchange; therefore, the closing prices for securities in such markets or on such exchanges may not fully reflect events that occur after such close but before the close of the New York Stock Exchange. In those situations, foreign securities will be fair valued pursuant to a policy approved by the Board of Trustees. Under the policy, the Fund may utilize a third-party pricing service to determine these fair values. The third-party pricing service takes into account multiple factors, including relevant general and sector indices, currency fluctuations, depositary receipts, and futures, as applicable, to determine a good faith estimate that reasonably reflects the current market conditions as of the close of the New York Stock Exchange. The fair value of a security is likely to be different from the quoted or published price, if available.
Investments in open-end investment companies (other than exchange-traded funds (ETFs)), are valued at the latest net asset value reported by those companies as of the valuation time.
Option contracts are valued at the mean of the latest quoted bid and ask prices on their primary exchanges. Option contracts, including over-the-counter option contracts, with no readily available market quotations are valued using mid-market evaluations from independent third-party vendors.
Swap transactions are valued through an independent pricing service or broker, or if neither is available, through an internal model based upon observable inputs.
32
Multi-Manager Directional Alternative Strategies Fund  | 2024

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
Investments for which market quotations are not readily available, or that have quotations which management believes are not reflective of market value or reliable, are valued at fair value as determined in good faith under procedures approved by the Board of Trustees. If a security or class of securities (such as foreign securities) is valued at fair value, such value is likely to be different from the quoted or published price for the security, if available.
The determination of fair value often requires significant judgment. To determine fair value, management may use assumptions including but not limited to future cash flows and estimated risk premiums. Multiple inputs from various sources may be used to determine fair value.
GAAP requires disclosure regarding the inputs and valuation techniques used to measure fair value and any changes in valuation inputs or techniques. In addition, investments shall be disclosed by major category. This information is disclosed following the Fund’s Portfolio of Investments.
Foreign currency transactions and translations
The values of all assets and liabilities denominated in foreign currencies are generally translated into U.S. dollars at exchange rates determined at the close of regular trading on the New York Stock Exchange. Net realized and unrealized gains (losses) on foreign currency transactions and translations include gains (losses) arising from the fluctuation in exchange rates between trade and settlement dates on securities transactions, gains (losses) arising from the disposition of foreign currency and currency gains (losses) between the accrual and payment dates on dividends, interest income and foreign withholding taxes.
For financial statement purposes, the Fund does not distinguish that portion of gains (losses) on investments which is due to changes in foreign exchange rates from that which is due to changes in market prices of the investments. Such fluctuations are included with the net realized and unrealized gains (losses) on investments in the Statement of Operations.
Derivative instruments
The Fund invests in certain derivative instruments, as detailed below, in seeking to meet its investment objectives. Derivatives are instruments whose values depend on, or are derived from, in whole or in part, the value of one or more securities, currencies, commodities, indices, or other assets or instruments. Derivatives may be used to increase investment flexibility (including to maintain cash reserves while maintaining desired exposure to certain assets), for risk management (hedging) purposes, to facilitate trading, to reduce transaction costs and to pursue higher investment returns. The Fund may also use derivative instruments to mitigate certain investment risks, such as foreign currency exchange rate risk, interest rate risk and credit risk. Derivatives may involve various risks, including the potential inability of the counterparty to fulfill its obligations under the terms of the contract, the potential for an illiquid secondary market (making it difficult for the Fund to sell or terminate, including at favorable prices) and the potential for market movements which may expose the Fund to gains or losses in excess of the amount shown in the Statement of Assets and Liabilities. The notional exposure of a financial instrument is the nominal or face amount that is used to calculate payments made on that instrument and/or changes in value for the instrument. The notional exposure is a hypothetical underlying quantity upon which payment obligations are computed. Notional exposures provide a gauge for how the Fund may behave given changes in the underlying rate, asset or reference instrument and individual markets. The notional amounts of derivative instruments, if applicable, are not recorded in the financial statements.
A derivative instrument may suffer a marked-to-market loss if the value of the contract decreases due to an unfavorable change in the market rates or values of the underlying instrument. Losses can also occur if the counterparty does not perform its obligations under the contract. The Fund’s risk of loss from counterparty credit risk on over-the-counter derivatives generally is expected to be limited to the aggregate unrealized gain netted against any collateral held by the Fund and the amount of any variation margin held by the counterparty, plus any replacement costs or related amounts. With exchange-traded or centrally cleared derivatives, there is reduced counterparty credit risk to the Fund since the clearinghouse or central counterparty provides some protection in the case of clearing member default. The clearinghouse or central counterparty stands between the buyer and the seller of the contract; therefore, failure of the clearinghouse or central counterparty may pose additional counterparty credit risk. However, credit risk still exists in exchange-traded or centrally cleared derivatives with respect to initial and variation margin that is held in a broker’s customer account. While clearing brokers are required to segregate customer margin from their own assets, in the event that a clearing broker becomes
Multi-Manager Directional Alternative Strategies Fund  | 2024
33

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
insolvent or goes into bankruptcy and at that time there is a shortfall in the aggregate amount of margin held by the clearing broker for all its clients and such shortfall is remedied by the central counterparty or otherwise, U.S. bankruptcy laws will typically allocate that shortfall on a pro-rata basis across all the clearing broker’s customers (including the Fund), potentially resulting in losses to the Fund.
In order to better define its contractual rights and to secure rights that will help the Fund mitigate its counterparty risk in respect of over-the-counter derivatives, the Fund may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (ISDA Master Agreement) or similar agreement with its derivatives counterparties. An ISDA Master Agreement is an agreement between the Fund and a counterparty that governs over-the-counter derivatives and foreign exchange forward contracts and contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. Under an ISDA Master Agreement, the Fund may, under certain circumstances, offset with the counterparty certain derivative instruments’ payables and/or receivables with collateral held and/or posted and create one single net payment. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of default (close-out netting), including the bankruptcy or insolvency of the counterparty. Note, however, that bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against the right of offset or netting in bankruptcy, insolvency or other events.
Collateral (margin) requirements differ by type of derivative. Margin requirements are established by the clearinghouse or central counterparty for exchange-traded and centrally cleared derivatives. Brokers can ask for margin in excess of the minimum in certain circumstances. Collateral terms for most over-the-counter derivatives are subject to regulatory requirements to exchange variation margin with trading counterparties and may have contract specific margin terms as well. For over-the-counter derivatives traded under an ISDA Master Agreement, the collateral requirements are typically calculated by netting the marked-to-market amount for each transaction under such agreement and comparing that amount to the value of any variation margin currently pledged by the Fund and/or the counterparty. Generally, the amount of collateral due from or to a party has to exceed a minimum transfer amount threshold (e.g., $250,000) before a transfer has to be made. To the extent amounts due to the Fund from its counterparties are not fully collateralized, contractually or otherwise, the Fund bears the risk of loss from counterparty nonperformance. The Fund may also pay interest expense on cash collateral received from the broker or receive interest income on cash collateral pledged to the broker. The Fund attempts to mitigate counterparty risk by only entering into agreements with counterparties that it believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties.
Certain ISDA Master Agreements allow counterparties of over-the-counter derivatives transactions to terminate derivatives contracts prior to maturity in the event the Fund’s net asset value declines by a stated percentage over a specified time period or if the Fund fails to meet certain terms of the ISDA Master Agreement, which would cause the Fund to accelerate payment of any net liability owed to the counterparty.  The Fund also has termination rights if the counterparty fails to meet certain terms of the ISDA Master Agreement.  In determining whether to exercise such termination rights, the Fund would consider, in addition to counterparty credit risk, whether termination would result in a net liability owed from the counterparty.
For financial reporting purposes, the Fund does not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statement of Assets and Liabilities.
Options contracts
Options are contracts which entitle the holder to purchase or sell securities or other identified assets at a specified price, or in the case of index option contracts, to receive or pay the difference between the index value and the strike price of the index option contract. Option contracts can be either exchange-traded or over-the-counter. The Fund purchased and has written option contracts to produce incremental earnings, to decrease the Fund’s exposure to equity risk, to increase return on investments, to protect gains and to facilitate buying and selling of securities for investments. These instruments may be used for other purposes in future periods. Completion of transactions for option contracts traded in the over-the-counter market depends upon the performance of the other party. Collateral may be collected or posted by the Fund to secure over-the-counter option contract trades. Collateral held or posted by the Fund for such option contract trades must be returned to the broker or the Fund upon closure, exercise or expiration of the contract.
34
Multi-Manager Directional Alternative Strategies Fund  | 2024

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
Options contracts purchased are recorded as investments. When the Fund writes an options contract, the premium received is recorded as an asset and an amount equivalent to the premium is recorded as a liability in the Statement of Assets and Liabilities and is subsequently adjusted to reflect the current fair value of the option written. Changes in the fair value of the written option are recorded as unrealized appreciation or depreciation until the contract is exercised or has expired. The Fund realizes a gain or loss when the option contract is closed or expires. When option contracts are exercised, the proceeds on sales for a written call or purchased put option contract, or the purchase cost for a written put or purchased call option contract, is adjusted by the amount of premium received or paid.
For over-the-counter options purchased, the Fund bears the risk of loss of the amount of the premiums paid plus the positive change in market values net of any collateral held by the Fund should the counterparty fail to perform under the contracts. Option contracts written by the Fund do not typically give rise to significant counterparty credit risk, as options written generally obligate the Fund and not the counterparty to perform. The risk in writing a call option contract is that the Fund gives up the opportunity for profit if the market price of the security increases above the strike price and the option contract is exercised. The risk in writing a put option contract is that the Fund may incur a loss if the market price of the security decreases below the strike price and the option contract is exercised. Exercise of a written option could result in the Fund purchasing or selling a security or foreign currency when it otherwise would not, or at a price different from the current market value. In purchasing and writing options, the Fund bears the risk of an unfavorable change in the value of the underlying instrument or the risk that the Fund may not be able to enter into a closing transaction due to an illiquid market.
Swap contracts
Swap contracts are negotiated in the over-the-counter market and are entered into bilaterally or centrally cleared (centrally cleared swap contract). In a centrally cleared swap contract, immediately following execution of the swap contract with a broker, the swap contract is novated to a central counterparty and the central counterparty becomes the Fund’s counterparty to the centrally cleared swap contract. The Fund is required to deposit initial margin with the futures commission merchant (FCM), which pledges it through to the central counterparty in the form of cash or securities in an amount that varies depending on the size and risk profile of the particular swap contract. Securities deposited as initial margin are designated in the Portfolio of Investments and cash deposited is recorded in the Statement of Assets and Liabilities as margin deposits. For a bilateral swap contract, the Fund has credit exposure to the broker, but exchanges daily variation margin with the broker based on the mark-to-market value of the swap contract to minimize that exposure. For centrally cleared swap contracts, there is less credit exposure to the FCM than in the case of an over-the-counter derivative, because the central counterparty stands between the Fund and the relevant buyer/seller on the other side of the contract. Swap contracts are marked-to-market daily and changes in value are recorded as unrealized appreciation (depreciation). The daily change in valuation of centrally cleared swap contracts, if any, is recorded as a receivable or payable for variation margin in the Statement of Assets and Liabilities.
Entering into these contracts involves, to varying degrees, elements of interest, liquidity and counterparty credit risk in excess of the amounts recognized in the Statement of Assets and Liabilities. Such risks involve the possibility that there may be unfavorable changes in interest rates, market conditions or other conditions, that it may be difficult to initiate a swap transaction or liquidate a position at an advantageous time or price which may result in significant losses, and that the bilateral counterparty, FCM or central counterparty, as applicable, may not fulfill its obligation under the contract.
Total return swap contracts
The Fund entered into total return swap contracts to manage long or short exposure to the total return on a specified reference security in return for periodic payments based on a fixed or variable interest rate. These instruments may be used for other purposes in future periods. Total return swap contracts may be used to obtain exposure to an underlying reference security, instrument, or other asset or index or market without owning, taking physical custody of, or short selling any such security, instrument or asset in a market.
Total return swap contracts are valued daily, and the change in value is recorded as unrealized appreciation (depreciation) until the termination of the swap, at which time the Fund will realize a gain (loss). Periodic payments received (or made) by the Fund over the term of the contract are recorded as realized gains (losses). Total return swap contracts are subject to the risk associated with the investment in the underlying reference security, instrument or asset. This risk may be offset if the
Multi-Manager Directional Alternative Strategies Fund  | 2024
35

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
Fund holds any of the underlying reference security, instrument or asset. Total return swap contracts are subject to the risk that the counterparty may not fulfill its obligations under the contract. This risk is offset by the daily exchange of variation margin with the swap counterparty.
Effects of derivative transactions in the financial statements
The following tables are intended to provide additional information about the effect of derivatives on the financial statements of the Fund, including: the fair value of derivatives by risk category and the location of those fair values in the Statement of Assets and Liabilities; and the impact of derivative transactions over the period in the Statement of Operations, including realized and unrealized gains (losses). The derivative instrument schedules following the Portfolio of Investments present additional information regarding derivative instruments outstanding at the end of the period, if any.
The following table is a summary of the fair value of derivative instruments (not considered to be hedging instruments for accounting disclosure purposes) at October 31, 2024: 
 
Asset derivatives
 
Risk exposure
category
Statement
of assets and liabilities
location
Fair value ($)
Equity risk
Investments, at value — Option contracts purchased
4,986,390
Equity risk
Component of total distributable earnings (loss) — unrealized appreciation on swap contracts
2,144,115
*
Total
 
7,130,505
 
 
Liability derivatives
 
Risk exposure
category
Statement
of assets and liabilities
location
Fair value ($)
Equity risk
Option contracts written, at value
321,425
Equity risk
Component of total distributable earnings (loss) — unrealized depreciation on swap contracts
2,975,832
*
Total
 
3,297,257
 
*
Includes cumulative appreciation (depreciation) as reported in the tables following the Portfolio of Investments. Only the current day’s variation margin for futures and centrally cleared swaps, if any, is reported in receivables or payables in the Statement of Assets and Liabilities.
The following table indicates the effect of derivative instruments (not considered to be hedging instruments for accounting disclosure purposes) in the Statement of Operations for the six months ended October 31, 2024: 
Amount of realized gain (loss) on derivatives recognized in income
Risk exposure category
Option
contracts
purchased
($)
Option
contracts
written
($)
Swap
contracts
($)
Total
($)
Equity risk
(4,004,070
)
(92,574
)
6,364,353
2,267,709
 
Change in unrealized appreciation (depreciation) on derivatives recognized in income
Risk exposure category
Option
contracts
purchased
($)
Option
contracts
written
($)
Swap
contracts
($)
Total
($)
Equity risk
(930,769
)
20,887
(831,717
)
(1,741,599
)
The following table is a summary of the average daily outstanding volume by derivative instrument for the six months ended October 31, 2024: 
Derivative instrument
Average
value ($)
Option contracts purchased
2,041,732
Option contracts written
(136,540
)
 
36
Multi-Manager Directional Alternative Strategies Fund  | 2024

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
Derivative instrument
Average unrealized
appreciation ($)
Average unrealized
depreciation ($)
Total return swap contracts
969,559
(803,779
)
Short sales
The Fund may sell a security it does not own in anticipation of a decline in the fair value of the security. When the Fund sells a security short, it must borrow the security sold short and deliver it to the broker-dealer through which it made the short sale. The Fund is required to maintain a margin account with the broker and to pledge assets to the broker as collateral for the borrowed security. Securities pledged as collateral are designated in the Portfolio of Investments. In addition, the collateral is recorded as cash collateral held at broker in the Statement of Assets and Liabilities. The Fund can purchase the same security at the current market price and deliver it to the broker to close out the short sale. The Fund is obligated to pay the broker a fee for borrowing the security and may receive rebate income from the investment of collateral. The net amount of income or fees is included in "Interest income" (for net income received) or “Dividends and interest on securities sold short” (for net expense) in the Statement of Operations. A short position is reported as a liability at fair value in the Statement of Assets and Liabilities. The Fund must also pay the broker for any dividends accrued (recognized on ex-date) on the borrowed security. This amount is recorded as an expense in the Statement of Operations. The Fund will record a gain if the security declines in value, and will realize a loss if the security appreciates. Such gain, limited to the price at which the Fund sold the security short, or such loss, potentially unlimited in size because the short position loses value as the market price of the security sold short increases, will be recognized upon the termination of a short sale.
Offsetting of assets and liabilities
The following table presents the Fund’s gross and net amount of assets and liabilities available for offset under netting arrangements as well as any related collateral received or pledged by the Fund as of October 31, 2024: 
 
JPMorgan ($)
Morgan
Stanley ($)(a)
Morgan
Stanley ($)(a)
Total ($)
Assets
Call option contracts purchased
-
2,365,726
-
2,365,726
Put option contracts purchased
-
2,620,664
-
2,620,664
OTC total return swap contracts (b)
-
-
2,144,115
2,144,115
Total assets
-
4,986,390
2,144,115
7,130,505
Liabilities
Call option contracts written
-
263,863
-
263,863
Put option contracts written
-
57,562
-
57,562
OTC total return swap contracts (b)
-
-
2,975,832
2,975,832
Securities borrowed
4,492,904
139,579,278
-
144,072,182
Total liabilities
4,492,904
139,900,703
2,975,832
147,369,439
Total financial and derivative net assets
(4,492,904
)
(134,914,313
)
(831,717
)
(140,238,934
)
Total collateral received (pledged) (c)
(4,492,904
)
(134,914,313
)
(831,717
)
(140,238,934
)
Net amount (d)
-
-
-
 
(a)
Exposure can only be netted across transactions governed under the same master agreement with the same legal entity.
(b)
Over-the-Counter (OTC) swap contracts are presented at market value plus periodic payments receivable (payable), which is comprised of unrealized appreciation, unrealized depreciation, upfront payments and upfront receipts.
(c)
In some instances, the actual collateral received and/or pledged may be more than the amount shown due to overcollateralization.
(d)
Represents the net amount due from/(to) counterparties in the event of default.
Security transactions
Security transactions are accounted for on the trade date. Cost is determined and gains (losses) are based upon the specific identification method for both financial statement and federal income tax purposes.
Income recognition
Interest income is recorded on an accrual basis.
Multi-Manager Directional Alternative Strategies Fund  | 2024
37

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
Corporate actions and dividend income are generally recorded net of any non-reclaimable tax withholdings, on the ex-dividend date or upon receipt of an ex-dividend notification in the case of certain foreign securities.
The Fund may receive distributions from holdings in equity securities, business development companies (BDCs), exchange-traded funds (ETFs), limited partnerships (LPs), other regulated investment companies (RICs), and real estate investment trusts (REITs), which report information as to the tax character of their distributions annually. These distributions are allocated to dividend income, capital gain and return of capital based on actual information reported. Return of capital is recorded as a reduction of the cost basis of securities held. If the Fund no longer owns the applicable securities, return of capital is recorded as a realized gain. With respect to REITs, to the extent actual information has not yet been reported, estimates for return of capital are made by Columbia Management Investment Advisers, LLC (the Investment Manager), a wholly-owned subsidiary of Ameriprise Financial, Inc. (Ameriprise Financial). The Investment Manager’s estimates are subsequently adjusted when the actual character of the distributions is disclosed by the REITs, which could result in a proportionate change in return of capital to shareholders.
Awards from class action litigation are recorded as a reduction of cost basis if the Fund still owns the applicable securities on the payment date. If the Fund no longer owns the applicable securities on the payment date, the proceeds are recorded as realized gains.
Expenses
General expenses of the Trust are allocated to the Fund and other funds of the Trust based upon relative net assets or other expense allocation methodologies determined by the nature of the expense. Expenses directly attributable to the Fund are charged to the Fund. Expenses directly attributable to a specific class of shares are charged to that share class.
Determination of class net asset value
All income, expenses (other than class-specific expenses, which are charged to that share class, as shown in the Statement of Operations) and realized and unrealized gains (losses) are allocated to each class of the Fund on a daily basis, based on the relative net assets of each class, for purposes of determining the net asset value of each class.
Federal income tax status
The Fund intends to qualify each year as a regulated investment company under Subchapter M of the Internal Revenue Code, as amended, and will distribute substantially all of its investment company taxable income and net capital gain, if any, for its tax year, and as such will not be subject to federal income taxes. In addition, the Fund intends to distribute in each calendar year substantially all of its ordinary income, capital gain net income and certain other amounts, if any, such that the Fund should not be subject to federal excise tax. Therefore, no federal income or excise tax provision is recorded.
Foreign taxes
The Fund may be subject to foreign taxes on income, gains on investments or currency repatriation, a portion of which may be recoverable. The Fund will accrue such taxes and recoveries, as applicable, based upon its current interpretation of tax rules and regulations that exist in the markets in which it invests.
Realized gains in certain countries may be subject to foreign taxes at the Fund level, based on statutory rates. The Fund accrues for such foreign taxes on realized and unrealized gains at the appropriate rate for each jurisdiction, as applicable. The amount, if any, is disclosed as a liability in the Statement of Assets and Liabilities.
Distributions to shareholders
Distributions from net investment income, if any, are declared and paid annually. Net realized capital gains, if any, are distributed at least annually. Income distributions and capital gain distributions are determined in accordance with federal income tax regulations, which may differ from GAAP.
38
Multi-Manager Directional Alternative Strategies Fund  | 2024

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
Guarantees and indemnifications
Under the Trust’s organizational documents and, in some cases, by contract, its officers and trustees are indemnified against certain liabilities arising out of the performance of their duties to the Trust or its funds. In addition, certain of the Fund’s contracts with its service providers contain general indemnification clauses. The Fund’s maximum exposure under these arrangements is unknown since the amount of any future claims that may be made against the Fund cannot be determined, and the Fund has no historical basis for predicting the likelihood of any such claims.
Note 3. Fees and other transactions with affiliates
Management services fees
The Fund has entered into a Management Agreement with Columbia Management Investment Advisers, LLC (the Investment Manager), a wholly-owned subsidiary of Ameriprise Financial, Inc. (Ameriprise Financial). Under the Management Agreement, the Investment Manager provides the Fund with investment research and advice, as well as administrative and accounting services. The Investment Manager is responsible for the ultimate oversight of investments made by the Fund. The Fund’s subadvisers (see Subadvisory agreements below) have the primary responsibility for the day-to-day portfolio management of the Fund. The management services fee is equal to 1.60% of the Fund’s daily net assets.
Effective September 5, 2023 (Waiver Effective Date), the Investment Manager started to voluntarily waive a portion of its management fee effective on Fund assets formerly managed by a Fund subadviser that was terminated on the Waiver Effective Date (the Former Subadviser’s Sleeve), which assets have been managed directly by the Investment Manager since that date. The Investment Manager waived its management fees in an amount equal to the subadvisory fees that would have been paid by the Investment Manager to the former subadviser with respect to the Former Subadviser’s Sleeve (based on the fee schedule in the terminated subadvisory agreement between the Investment Manager and the former subadviser and the daily value of such assets). This voluntary management fee waiver was not taken into account as an offset to the Fund’s operating expenses when calculating an existing contractual fee waiver/reimbursement arrangement between the Fund and the Investment Manager. Effective July 23, 2024, this voluntary waiver arrangement was terminated.
Subadvisory agreements
The Investment Manager has entered into Subadvisory Agreements with Allspring Global Investments, LLC and Boston Partners Global Investors, Inc., each of which subadvises a portion of the assets of the Fund. Effective July 24, 2024, the Investment Manager has entered into a Subadvisory Agreement with Summit Partners Public Asset Management, LLC to serve as a subadviser to a portion of the assets of the Fund. New investments in the Fund, net of any redemptions, are allocated in accordance with the Investment Manager’s determination. Each subadviser’s proportionate share of investments in the Fund will vary due to market fluctuations. The Investment Manager compensates each subadviser to manage the investment of the Fund’s assets.
Compensation of Board members
Members of the Board of Trustees who are not officers or employees of the Investment Manager or Ameriprise Financial are compensated for their services to the Fund as disclosed in the Statement of Operations. Under a Deferred Compensation Plan (the Deferred Plan), these members of the Board of Trustees may elect to defer payment of up to 100% of their compensation. Deferred amounts are treated as though equivalent dollar amounts had been invested in shares of certain funds managed by the Investment Manager. The Fund’s liability for these amounts is adjusted for market value changes and remains in the Fund until distributed in accordance with the Deferred Plan. All amounts payable under the Deferred Plan constitute a general unsecured obligation of the Fund. The expense for the Deferred Plan, which includes Trustees’ fees deferred during the current period as well as any gains or losses on the Trustees’ deferred compensation balances as a result of market fluctuations, is included in "Deferred compensation of board members" in the Statement of Operations.
Compensation of Chief Compliance Officer
The Board of Trustees has appointed a Chief Compliance Officer for the Fund in accordance with federal securities regulations. As disclosed in the Statement of Operations, a portion of the Chief Compliance Officer’s total compensation is allocated to the Fund, along with other allocations to affiliated registered investment companies managed by the Investment Manager and its affiliates, based on relative net assets.
Multi-Manager Directional Alternative Strategies Fund  | 2024
39

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
Transfer agency fees
Under a Transfer and Dividend Disbursing Agent Agreement, Columbia Management Investment Services Corp. (the Transfer Agent), an affiliate of the Investment Manager and a wholly-owned subsidiary of Ameriprise Financial, is responsible for providing transfer agency services to the Fund. The Transfer Agent has contracted with SS&C GIDS, Inc. (SS&C GIDS) to serve as sub-transfer agent. The Transfer Agent pays the fees of SS&C GIDS for services as sub-transfer agent and SS&C GIDS is not entitled to reimbursement for such fees from the Fund (with the exception of out-of-pocket fees).
The Fund pays the Transfer Agent a monthly transfer agency fee based on the number or the average value of accounts, depending on the type of account. In addition, the Fund pays the Transfer Agent a fee for shareholder services based on the number of accounts or on a percentage of the average aggregate value of the Fund’s shares maintained in omnibus accounts up to the lesser of the amount charged by the financial intermediary or a cap established by the Board of Trustees from time to time.
The Transfer Agent also receives compensation from the Fund for various shareholder services and reimbursements for certain out-of-pocket fees.
For the six months ended October 31, 2024, the Fund’s annualized effective transfer agency fee rate as a percentage of average daily net assets was as follows: 
 
Effective rate (%)
Institutional Class
0.20
Distribution and service fees
The Fund has an agreement with Columbia Management Investment Distributors, Inc. (the Distributor), an affiliate of the Investment Manager and a wholly-owned subsidiary of Ameriprise Financial, for distribution and shareholder services. The Fund does not pay the Distributor a fee for the distribution services it provides to the Fund.
Expenses waived/reimbursed by the Investment Manager and its affiliates
The Investment Manager and certain of its affiliates have contractually agreed to waive fees and/or reimburse expenses (excluding certain fees and expenses described below) for the period(s) disclosed below, unless sooner terminated at the sole discretion of the Board of Trustees, so that the Fund’s net operating expenses, after giving effect to fees waived/expenses reimbursed and any balance credits and/or overdraft charges from the Fund’s custodian, do not exceed the following annual rate(s) as a percentage of the classes’ average daily net assets: 
 
September 1, 2024
through
August 31, 2025 (%)
Prior to
September 1, 2024 (%)
Institutional Class
1.82
1.84
Under the agreement governing these fee waivers and/or expense reimbursement arrangements, the following fees and expenses are excluded from the waiver/reimbursement commitment, and therefore will be paid by the Fund, if applicable: taxes (including foreign transaction taxes), expenses associated with investments in affiliated and non-affiliated pooled investment vehicles (including mutual funds and exchange-traded funds), transaction costs and brokerage commissions, costs related to any securities lending program, dividend expenses associated with securities sold short, inverse floater program fees and expenses, transaction charges and interest on borrowed money, interest, costs associated with shareholder meetings, infrequent and/or unusual expenses and any other expenses the exclusion of which is specifically approved by the Board of Trustees. The Fund’s management services fee voluntary waiver, which took effect on September 5, 2023, is also excluded from the waiver/reimbursement commitment and, therefore, provides an additional benefit to the Fund’s shareholders. Effective July 23, 2024, this voluntary waiver arrangement was terminated. This agreement may be modified or amended only with approval from the Investment Manager, certain of its affiliates and the Fund. Any fees waived and/or expenses reimbursed under the expense reimbursement arrangements described above are not recoverable by the Investment Manager or its affiliates in future periods.
40
Multi-Manager Directional Alternative Strategies Fund  | 2024

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
Note 4. Federal tax information
The timing and character of income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP because of temporary or permanent book to tax differences.
At October 31, 2024, the approximate cost of all investments for federal income tax purposes and the aggregate gross approximate unrealized appreciation and depreciation based on that cost was: 
Federal
tax cost ($)
Gross unrealized
appreciation ($)
Gross unrealized
(depreciation) ($)
Net unrealized
appreciation ($)
87,885,000
65,371,000
(15,553,000
)
49,818,000
Tax cost of investments and unrealized appreciation/(depreciation) may also include timing differences that do not constitute adjustments to tax basis.
Management of the Fund has concluded that there are no significant uncertain tax positions in the Fund that would require recognition in the financial statements. However, management’s conclusion may be subject to review and adjustment at a later date based on factors including, but not limited to, new tax laws, regulations, and administrative interpretations (including relevant court decisions). Generally, the Fund’s federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
Note 5. Portfolio information
The cost of purchases and proceeds from sales of securities, excluding short-term investments and derivatives, if any, aggregated to $436,984,049 and $506,636,506, respectively, for the six months ended October 31, 2024. The amount of purchase and sale activity impacts the portfolio turnover rate reported in the Financial Highlights.
Brokerage commissions paid to brokers affiliated with the Investment Manager of the Fund were $362 for the six months ended October 31, 2024.
Note 6. Affiliated money market fund
The Fund invests in Columbia Short-Term Cash Fund, an affiliated money market fund established for the exclusive use by the Fund and other affiliated funds (the Affiliated MMF). The income earned by the Fund from such investments is included as Dividends - affiliated issuers in the Statement of Operations. As an investing fund, the Fund indirectly bears its proportionate share of the expenses of the Affiliated MMF. The Affiliated MMF prices its shares with a floating net asset value. The Securities and Exchange Commission has adopted amendments to money market fund rules requiring institutional prime money market funds like the Affiliated MMF to be subject to a discretionary liquidity fee of up to 2% if the imposition of such a fee is determined to be in the best interest of the Affiliated MMF and to a mandatory liquidity fee if daily net redemptions exceed 5% of net assets.
Note 7. Interfund lending
Pursuant to an exemptive order granted by the Securities and Exchange Commission, the Fund participates in a program (the Interfund Program) allowing each participating Columbia Fund (each, a Participating Fund) to lend money directly to and, except for closed-end funds and money market funds, borrow money directly from other Participating Funds for temporary purposes. The amounts eligible for borrowing and lending under the Interfund Program are subject to certain restrictions.
Interfund loans are subject to the risk that the borrowing fund could be unable to repay the loan when due, and a delay in repayment to the lending fund could result in lost opportunities and/or additional lending costs. The exemptive order is subject to conditions intended to mitigate conflicts of interest arising from the Investment Manager’s relationship with each Participating Fund.
Multi-Manager Directional Alternative Strategies Fund  | 2024
41

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
The Fund’s activity in the Interfund Program during the six months ended October 31, 2024 was as follows: 
Borrower or lender
Average loan
balance ($)
Weighted average
interest rate (%)
Number of days
with outstanding loans
Borrower
300,000
5.86
3
Lender
400,000
5.86
1
Interest income earned and interest expense incurred by the Fund are recorded as Interfund lending and Interest on interfund lending, respectively, in the Statement of Operations. The Fund had no outstanding interfund loans at October 31, 2024.
Note 8. Line of credit
The Fund has access to a revolving credit facility with a syndicate of banks led by JPMorgan Chase Bank, N.A., Citibank, N.A. and Wells Fargo Bank, N.A. whereby the Fund may borrow for the temporary funding of shareholder redemptions or for other temporary or emergency purposes. Pursuant to an October 24, 2024 amendment and restatement, the credit facility, which is an agreement between the Fund and certain other funds managed by the Investment Manager or an affiliated investment manager, severally and not jointly, permits aggregate borrowings up to $900 million. Interest is currently charged to each participating fund based on its borrowings at a rate equal to the higher of (i) the federal funds effective rate, (ii) the secured overnight financing rate plus 0.10% and (iii) the overnight bank funding rate, plus 1.00% in each case. Each borrowing under the credit facility matures no later than 60 days after the date of borrowing. The Fund also pays a commitment fee equal to its pro rata share of the unused amount of the credit facility at a rate of 0.15% per annum. The commitment fee is included in other expenses in the Statement of Operations. This agreement expires annually in October unless extended or renewed. Prior to the October 24, 2024 amendment and restatement, the Fund had access to a revolving credit facility with a syndicate of banks led by JPMorgan Chase Bank, N.A., Citibank, N.A. and Wells Fargo Bank, N.A. which permitted collective borrowings up to $900 million. Interest was charged to each participating fund based on its borrowings at a rate equal to the higher of (i) the federal funds effective rate, (ii) the secured overnight financing rate plus 0.10% and (iii) the overnight bank funding rate, plus 1.00% in each case.
The Fund had no borrowings during the six months ended October 31, 2024.
Note 9. Significant risks
Alternative strategies investment risk
An investment in alternative investment strategies (Alternative Strategies) involves risks, which may be significant. Alternative Strategies may include strategies, instruments or other assets, such as derivatives, that seek investment returns uncorrelated with the broad equity and fixed income/debt markets, as well as those providing exposure to other markets (such as commodity markets), including but not limited to absolute (positive) return strategies. Alternative Strategies may fail to achieve their desired performance, market or other exposure, or their returns (or lack thereof) may be more correlated with the broad equity and/or fixed income/debt markets than was anticipated, and the Fund may lose money.
Derivatives risk
Losses involving derivative instruments may be substantial, because a relatively small movement in the underlying reference (which is generally the price, rate or other economic indicator associated with a security(ies), commodity, currency, index or other instrument or asset) may result in a substantial loss for the Fund. In addition to the potential for increased losses, the use of derivative instruments may lead to increased volatility within the Fund. Derivatives will typically increase the Fund’s exposure to principal risks to which it is otherwise exposed, and may expose the Fund to additional risks, including correlation risk, counterparty risk, hedging risk, leverage risk, liquidity risk and pricing risk.
Market risk
The Fund may incur losses due to declines in the value of one or more securities in which it invests. These declines may be due to factors affecting a particular issuer, or the result of, among other things, political, regulatory, market, economic or social developments affecting the relevant market(s) more generally. In addition, turbulence in financial markets and reduced liquidity in equity, credit and/or fixed income markets may negatively affect many issuers, which could adversely affect the Fund’s ability to price or value hard-to-value assets in thinly traded and closed markets and could cause significant
42
Multi-Manager Directional Alternative Strategies Fund  | 2024

Notes to Financial Statements (continued)
October 31, 2024 (Unaudited)
redemptions and operational challenges. Global economies and financial markets are increasingly interconnected, and conditions and events in one country, region or financial market may adversely impact issuers in a different country, region or financial market. These risks may be magnified if certain events or developments adversely interrupt the global supply chain; in these and other circumstances, such risks might affect companies worldwide. As a result, local, regional or global events such as terrorism, war, other conflicts, natural disasters, disease/virus outbreaks and epidemics or other public health issues, recessions, depressions or other events – or the potential for such events – could have a significant negative impact on global economic and market conditions.
Shareholder concentration risk
At October 31, 2024, affiliated shareholders of record owned 100.0% of the outstanding shares of the Fund in one or more accounts. Fund shares sold to or redeemed by concentrated accounts may have a significant effect on the operations of the Fund. In the case of a large redemption, the Fund may be forced to sell investments at inopportune times, including its liquid positions, which may result in Fund losses and the Fund holding a higher percentage of less liquid positions. Large redemptions could result in decreased economies of scale and increased operating expenses for non-redeeming Fund shareholders.
Short positions risk
The Fund may establish short positions which introduce more risk to the Fund than long positions (where the Fund owns the instrument or other asset) because the maximum sustainable loss on an instrument or other asset purchased (held long) is limited to the amount paid for the instrument or other asset plus the transaction costs, whereas there is no maximum price of the shorted instrument or other asset when purchased in the open market. Therefore, in theory, short positions have unlimited risk. The Fund’s use of short positions in effect “leverages” the Fund. Leverage potentially exposes the Fund to greater risks of loss due to unanticipated market movements, which may magnify losses and increase the volatility of returns. To the extent the Fund takes a short position in a derivative instrument or other asset, this involves the risk of a potentially unlimited increase in the value of the underlying instrument or other asset.
Note 10. Subsequent events
Management has evaluated the events and transactions that have occurred through the date the financial statements were issued and noted no items requiring adjustment of the financial statements or additional disclosure.
Note 11. Information regarding pending and settled legal proceedings
Ameriprise Financial and certain of its affiliates are involved in the normal course of business in legal proceedings which include regulatory inquiries, arbitration and litigation, including class actions concerning matters arising in connection with the conduct of their activities as part of a diversified financial services firm. Ameriprise Financial believes that the Fund is not currently the subject of, and that neither Ameriprise Financial nor any of its affiliates are the subject of, any pending legal, arbitration or regulatory proceedings that are likely to have a material adverse effect on the Fund or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Fund. Ameriprise Financial is required to make quarterly (10-Q), annual (10-K) and, as necessary, 8-K filings with the Securities and Exchange Commission (SEC) on legal and regulatory matters that relate to Ameriprise Financial and its affiliates. Copies of these filings may be obtained by accessing the SEC website at www.sec.gov.
There can be no assurance that these matters, or the adverse publicity associated with them, will not result in increased Fund redemptions, reduced sale of Fund shares or other adverse consequences to the Fund. Further, although we believe proceedings are not likely to have a material adverse effect on the Fund or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Fund, these proceedings are subject to uncertainties and, as such, we are unable to estimate the possible loss or range of loss that may result. An adverse outcome in one or more of these proceedings could result in adverse judgments, settlements, fines, penalties or other relief that could have a material adverse effect on the consolidated financial condition or results of operations of Ameriprise Financial or one or more of its affiliates that provide services to the Fund.
Multi-Manager Directional Alternative Strategies Fund  | 2024
43

Approval of Management and Subadvisory
Agreements
(Unaudited)
Columbia Management Investment Advisers, LLC (the Investment Manager, and together with its domestic and global affiliates, Columbia Threadneedle Investments), a wholly-owned subsidiary of Ameriprise Financial, Inc. (Ameriprise Financial), serves as the investment manager to Multi-Manager Directional Alternative Strategies Fund (the Fund).  Under a management agreement (the Management Agreement), the Investment Manager provides investment advice and other services to the Fund and other funds distributed by Columbia Management Investment Distributors, Inc. (collectively, the Funds). In addition, under the subadvisory agreements (the Subadvisory Agreements) between the Investment Manager and each of Allspring Global Investments, LLC (Allspring), Boston Partners Global Investors, Inc. (Boston Partners), and Summit Partners Public Asset Management, LLC (Summit) (collectively, the Subadvisers), the Subadvisers provide portfolio management and related services for the Fund.
On an annual basis, the Fund’s Board of Trustees (the Board), including the independent Board members (the Independent Trustees), considers renewal of the Management Agreement and the Subadvisory Agreements (together, the Advisory Agreements).  The Investment Manager prepared detailed reports for the Board and its Contracts Committee (including its Contracts Subcommittee) in March, April, May and June 2024, including reports providing the results of analyses performed by a third-party data provider, Broadridge Financial Solutions, Inc. (Broadridge), and comprehensive responses by the Investment Manager to written requests for information by independent legal counsel to the Independent Trustees (Independent Legal Counsel), to assist the Board in making this determination.  In addition, throughout the year, the Board (or its committees or subcommittees) regularly meets with portfolio management teams and senior management personnel and reviews information prepared by the Investment Manager addressing the services the Investment Manager provides and Fund performance.  The Board also accords appropriate weight to the work, deliberations and conclusions of the various committees (including their subcommittees), such as the Contracts Committee, the Investment Review Committee, the Audit Committee and the Compliance Committee in determining whether to continue the Advisory Agreements.
The Board, at its June 27, 2024 Board meeting (the June Meeting), considered the renewal of each of the Advisory Agreements for additional one-year terms.  At the June Meeting, Independent Legal Counsel reviewed with the Independent Trustees various factors relevant to the Board’s consideration of advisory and subadvisory agreements and the Board’s legal responsibilities related to such consideration.  The Independent Trustees considered such information as they, their legal counsel or the Investment Manager believed reasonably necessary to evaluate and to approve the continuation of each of the Advisory Agreements. Among other things, the information and factors considered included the following:

Information on the investment performance of the Fund relative to the performance of a group of mutual funds determined to be comparable to the Fund by Broadridge, as well as performance relative to one or more benchmarks; 

Information on the Fund’s management fees and total expenses, including information comparing the Fund’s expenses to those of a group of comparable mutual funds, as determined by Broadridge; 

The Investment Manager’s agreement to contractually limit or cap total operating expenses for the Fund so that total operating expenses (excluding certain fees and expenses, such as transaction costs and certain other investment related expenses, interest, taxes, acquired fund fees and expenses and infrequent and/or unusual expenses) would not exceed a specified annual rate, as a percentage of the Fund’s net assets;

Terms of the Advisory Agreements;

Subadvisory fees payable by the Investment Manager under the Subadvisory Agreements;

Descriptions of other agreements and arrangements with affiliates of the Investment Manager relating to the operations of the Fund, including agreements with respect to the provision of transfer agency and shareholder services to the Fund;

Descriptions of various services performed by the Investment Manager and the Subadvisers under the Advisory Agreements, including portfolio management and portfolio trading practices;

Information regarding any recently negotiated management fees of similarly-managed portfolios of other institutional clients of the Investment Manager;
44
Multi-Manager Directional Alternative Strategies Fund  | 2024

Approval of Management and Subadvisory
Agreements (continued)
(Unaudited) 

Information regarding the resources of the Investment Manager and Subadvisers, including information regarding senior management, portfolio managers and other personnel;

Information regarding the capabilities of the Investment Manager with respect to compliance monitoring services; 

The profitability to the Investment Manager and its affiliates from their relationships with the Fund; and

Report provided by the Board’s independent fee consultant, JDL Consultants, LLC (JDL).
Following an analysis and discussion of the foregoing, and the factors identified below, the Board, including all of the Independent Trustees, approved the renewal of each of the Advisory Agreements.
Nature, extent and quality of services provided by the Investment Manager and the Subadvisers
The Board analyzed various reports and presentations it had received detailing the services performed by the Investment Manager and the Subadvisers, as well as their history, expertise, resources and relative capabilities, and the qualifications of their personnel.
The Board specifically considered the many developments during recent years concerning the services provided by the Investment Manager, including, in particular, detailed information regarding the process employed for selecting and overseeing affiliated and unaffiliated subadvisers.  With respect to the Investment Manager, the Board also noted the organization and depth of the equity and credit research departments. The Board further observed the enhancements to the investment risk management department’s processes, systems and oversight over the past several years.  The Board also took into account the broad scope of services provided by the Investment Manager to each subadvised Fund, including, among other services, investment, risk and compliance oversight.  The Board also took into account the information it received concerning the Investment Manager’s ability to attract and retain key portfolio management personnel and that it has sufficient resources to provide competitive and adequate compensation to investment personnel.
In connection with the Board’s evaluation of the overall package of services provided by the Investment Manager, the Board also considered the nature, quality and range of administrative services provided to the Fund by the Investment Manager, as well as the achievements in 2023 in the performance of administrative services, and noted the various enhancements anticipated for 2024.  In evaluating the quality of services provided under the Advisory Agreements, the Board also took into account the organization and strength of the Fund’s and its service providers’ compliance programs.  The Board also reviewed the financial condition of the Investment Manager and its affiliates and each entity’s ability to carry out its responsibilities under the Management Agreement and the Fund’s other service agreements.
In addition, the Board discussed the acceptability of the terms of the Management Agreement (including the relatively broad scope of services required to be performed by the Investment Manager in addition to monitoring each Subadviser), noting that no changes were proposed from the forms of agreements previously approved. The Board also noted the wide array of legal and compliance services provided to the Fund under the Management Agreement.
The Board considered each Subadviser’s organizational strength and resources, portfolio management team depth and capabilities and investment process.  The Board also considered each Subadviser’s capability and wherewithal to carry out its responsibilities under the applicable Subadvisory Agreement.  In addition, the Board discussed the acceptability of the terms of the Subadvisory Agreements, including the scope of services required to be performed.  The Board noted that the terms of the Subadvisory Agreements are generally consistent with the terms of other subadvisory agreements for subadvisers who manage other funds managed by the Investment Manager.  It was observed that no changes were recommended to the Subadvisory Agreements. The Board took into account the Investment Manager’s representation that each Subadviser was in a position to provide quality services to the Fund. In this regard, the Board further observed the various services provided by the Investment Manager’s subadvisory oversight team.
Multi-Manager Directional Alternative Strategies Fund  | 2024
45

Approval of Management and Subadvisory
Agreements (continued)
(Unaudited) 
After reviewing these and related factors (including investment performance as discussed below), the Board concluded, within the context of their overall conclusions, that the nature, extent and quality of the services provided to the Fund under the Advisory Agreements supported the continuation of the Management Agreement and each of the Subadvisory Agreements.
Investment performance
The Board carefully reviewed the investment performance of the Fund, including detailed reports providing the results of analyses performed by each of the Investment Manager, Broadridge and JDL collectively showing, for various periods (including since manager inception): (i) the performance of the Fund, (ii) the Fund’s performance relative to peers and benchmarks and (iii) the net assets of the Fund.  The Board observed that the Fund’s performance for certain periods ranked above median based on information provided by Broadridge.
Additionally, the Board reviewed the performance of each of the Subadvisers and the Investment Manager’s process for monitoring such Subadvisers’ performance.  The Board considered, in particular, management’s rationale for recommending the continued retention of each Subadviser and management’s representations that the Investment Manager’s profitability is not the key factor driving their recommendation to select, renew or terminate a Subadviser. 
The Board also reviewed a description of the methodology for identifying the Fund’s peer groups for purposes of performance and expense comparisons. 
The Board also considered the Investment Manager’s and Subadvisers’ performance and reputation generally and the Investment Manager’s evaluation of the contribution of each Subadviser to the Fund’s investment mandate.  After reviewing these and related factors, the Board concluded, within the context of their overall conclusions, that the performance of the Fund, the Investment Manager and the Subadvisers, in light of other considerations, supported the continuation of the Management Agreement and each of the Subadvisory Agreements. 
Comparative fees, costs of services provided and the profits realized by the Investment Manager and its affiliates from their relationships with the Fund
The Board reviewed comparative fees and the costs of services provided under each of the Advisory Agreements.  The Board members considered detailed comparative information set forth in an annual report on fees and expenses, including, among other things, data (based on analyses conducted by Broadridge and JDL) showing a comparison of the Fund’s expenses with median expenses paid by funds in its comparative peer universe, as well as data showing the Fund’s contribution to the Investment Manager’s profitability. 
The Board considered the reports of JDL, which assisted in the Board’s analysis of the Funds’ performance and expenses and the reasonableness of the Funds’ fee rates.  The Board accorded particular weight to the notion that a primary objective of the level of fees is to achieve a rational pricing model applied consistently across the various product lines in the Fund family, while assuring that the overall fees for each Fund (with certain exceptions) are generally in line with the current “pricing philosophy” such that Fund total expense ratios, in general, approximate or are lower than the median expense ratios of funds in the same Lipper comparison universe. The Board took into account that the Fund’s total expense ratio (after considering proposed expense caps/waivers) approximated the peer universe’s median expense ratio.
Additionally, the Board reviewed the level of subadvisory fees paid to each Subadviser, noting that the fees are paid by the Investment Manager and do not impact the fees paid by the Fund.  The Board also reviewed advisory fee rates charged by other comparable mutual funds employing each Subadviser to provide comparable subadvisory services.  After reviewing these and related factors, the Board concluded, within the context of their overall conclusions, that the levels of management fees, subadvisory fees and expenses of the Fund, in light of other considerations, supported the continuation of the Management Agreement and each of the Subadvisory Agreements.
46
Multi-Manager Directional Alternative Strategies Fund  | 2024

Approval of Management and Subadvisory
Agreements (continued)
(Unaudited) 
The Board also considered the profitability of the Investment Manager and its affiliates in connection with the Investment Manager providing management services to the Fund.  Because the Subadvisory Agreements were negotiated at arms-length by the Investment Manager, which is responsible for payments to the Subadvisers thereunder, the Board did not consider the profitability to each Subadviser from its relationship with the Fund.  With respect to the profitability of the Investment Manager and its affiliates, the Independent Trustees referred to information discussing the profitability to the Investment Manager and Ameriprise Financial from managing, operating and distributing the Funds. The Board considered that the profitability generated by the Investment Manager in 2023 had declined from 2022 levels, due to a variety of factors, including the decreased assets under management of the Funds. It also took into account the indirect economic benefits flowing to the Investment Manager or its affiliates in connection with managing or distributing the Funds, such as the enhanced ability to offer various other financial products to Ameriprise Financial customers, soft dollar benefits and overall reputational advantages. The Board noted that the fees paid by the Fund should permit the Investment Manager to offer competitive compensation to its personnel, make necessary investments in its business and earn an appropriate profit.  After reviewing these and related factors, the Board concluded, within the context of their overall conclusions, that the costs of services provided and the profitability to the Investment Manager and its affiliates from their relationships with the Fund supported the continuation of the Management Agreement and each of the Subadvisory Agreements.
Economies of scale
The Board considered the potential existence of economies of scale in the provision by the Investment Manager of services to the Fund, and whether those economies of scale were shared with the Fund through breakpoints in investment management fees or other means, such as expense limitation arrangements and additional investments by the Investment Manager in investment, trading, compliance and other resources.  The Board considered the economies of scale that might be realized as the Fund’s net asset level grows and took note of the extent to which Fund shareholders might also benefit from such growth.  In this regard, the Board took into account that while the Management Agreement and Subadvisory Agreement with Summit did not provide for breakpoints, the Subadvisory Agreement with each of Allspring and Boston Partners provides for breakpoints that reduce the fees payable to each Subadviser as Fund assets grow and that there are additional opportunities through other means for sharing economies of scale with shareholders. 
Conclusion
The Board reviewed all of the above considerations in reaching its decision to approve the continuation of the Management Agreement and each of the Subadvisory Agreements.  In reaching its conclusions, no single factor was determinative. 
On June 27, 2024, the Board, including all of the Independent Trustees, determined that fees payable under each of the Advisory Agreements were fair and reasonable in light of the extent and quality of services provided and approved the renewal of each of the Advisory Agreements.
Multi-Manager Directional Alternative Strategies Fund  | 2024
47

Multi-Manager Directional Alternative Strategies Fund
P.O. Box 219104
Kansas City, MO 64121-9104
  
Please read and consider the investment objectives, risks, charges and expenses for any fund carefully before investing. For a prospectus and summary prospectus, which contains this and other important information about the Fund, go to
columbiathreadneedleus.com/investor/. The Fund is distributed by Columbia Management Investment Distributors, Inc., member FINRA, and managed by Columbia Management Investment Advisers, LLC.
Columbia Threadneedle Investments (Columbia Threadneedle) is the global brand name of the Columbia and Threadneedle group of companies. All rights reserved.
© 2024 Columbia Management Investment Advisers, LLC.
columbiathreadneedleus.com/investor/
SAR284_04_P01_(12/24)



Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.

Not applicable.



Item 9. Proxy Disclosures for Open-End Management Investment Companies.

Not applicable.



Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.

Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies is included in Item 7 of this Form N-CSR.



Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.

Statement regarding basis for approval of Investment Advisory Contract is included in Item 7 of this Form N-CSR.



Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.



Item 13. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.



Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.



Item 15. Submission of Matters to a Vote of Security Holders.

There were no material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of directors implemented since the registrant last provided disclosure as to such procedures in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K or Item 15 of Form N-CSR.



Item 16. Controls and Procedures.

(a) The registrant’s principal executive officer and principal financial officer, based on their evaluation of the registrant’s disclosure controls and procedures as of a date within 90 days of the filing of this report, have concluded that such controls and procedures are adequately designed to ensure that information required to be disclosed by the registrant in Form N-CSR is accumulated and communicated to the registrant’s management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

(b) There was no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.



Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.



Item 18. Recovery of Erroneously Awarded Compensation.

Not applicable.



 

Item 19. Exhibits.

(a)(1) Not applicable.

(a)(2) Certifications pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) attached hereto as Exhibit 99.CERT.

(b) Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) attached hereto as Exhibit 99.906CERT.

 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(registrant) Columbia Funds Series Trust I

By (Signature and Title) /s/ Daniel J. Beckman
Daniel J. Beckman, President and Principal Executive Officer

Date December 20, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title) /s/ Daniel J. Beckman
Daniel J. Beckman, President and Principal Executive Officer

Date December 20, 2024

By (Signature and Title) /s/ Michael G. Clarke
Michael G. Clarke, Chief Financial Officer,
Principal Financial Officer and Senior Vice President

Date December 20, 2024

By (Signature and Title) /s/ Charles H. Chiesa
Charles H. Chiesa, Treasurer, Chief Accounting
Officer and Principal Financial Officer

Date December 20, 2024